aspirin has been researched along with sulfinpyrazone in 398 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 376 (94.47) | 18.7374 |
| 1990's | 16 (4.02) | 18.2507 |
| 2000's | 4 (1.01) | 29.6817 |
| 2010's | 2 (0.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baggaley, KH; English, PD; Jennings, LJ; Morgan, B; Nunn, B; Tyrrell, AW | 1 |
| Strassburg, CP; Tukey, RH | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Jobin, F | 2 |
| Glusa, E | 1 |
| Haft, JI | 1 |
| Bream, ML; Ferguson, GG; Philp, RB | 1 |
| Kinlough-Rathbone, RL; Mustard, JF; Packham, MA; Perry, DW | 1 |
| Loo, J | 1 |
| Hanson, SR; Harker, LA | 2 |
| Ali, M; McDonald, JW | 2 |
| Verstraete, M | 7 |
| Allain, P; Leblondel, G | 1 |
| Rosenberg, JC; Sell, TL | 1 |
| Rosenberg, JC; Sell, T | 1 |
| Ferber, RH; Parrish, SL; Vigdahl, RL | 1 |
| Cameron, JS; Clark, WF; George, CR | 1 |
| Avellone, G; Davì, G; Mandalà, V; Novo, S; Pinto, A; Riolo, FP | 1 |
| Deykin, D; Gurewich, V; Harker, L; Hirsch, J | 1 |
| Dawson, A; Lavinski, C; Parsons, V; Weston, MJ | 1 |
| Mustard, JF; Packham, MA | 2 |
| Loeliger, EA | 1 |
| Courtney, JM; Forbes, CD; Prentice, CR; Reavey, M; Winchester, JF | 1 |
| Didisheim, P; Fuster, V | 2 |
| Weiss, HJ | 4 |
| Hirsh, J; Turpie, AG | 1 |
| Kinlough-Rathbone, RL; Mustard, JF; Packham, MA | 4 |
| Furlan, AJ; Sandok, BA; Sundt, TM; Whisnant, JP | 1 |
| Gordon, JL; Pearson, JD | 1 |
| Yasunaga, K | 1 |
| Byrnes, JJ; Lian, EC | 1 |
| Barnett, HJ | 3 |
| Hirsh, J | 5 |
| Kurtzke, JF | 1 |
| Barnett, HJ; Gent, M; Sackett, DL; Taylor, DW | 2 |
| Armitage, P | 2 |
| Dettori, AG; Pini, M; Quintavalla, R | 1 |
| Albert, EN; Bailey, JM; Daniel, RE; Whiting, JD | 1 |
| Latour, JG | 1 |
| Dmoszyńska-Giannopoulou, A; Pluta, A | 1 |
| Mitchell, JR | 2 |
| Novo, S; Strano, A | 1 |
| Ostendorf, P | 1 |
| Gantmacher, ML | 1 |
| Elwood, PC | 1 |
| al-Mefty, O; Marano, G; Nugent, GR; Raiaraman, S; Rodman, N | 1 |
| Oelz, O | 2 |
| Mehta, J; Mehta, P | 1 |
| Blümel, G; Fritsche, HM; Haas, S; Ketterl, R; Leimgruber, D | 1 |
| Ciammaichella, A | 1 |
| Cazenave, JP; Davies, JA; Essien, E; Gent, M; Kinlough-Rathbone, RL; Mustard, JF | 1 |
| Silvestri, G | 1 |
| Gent, M | 1 |
| Hladovec, J | 4 |
| Zabel Langhennig, R | 1 |
| Adams, JH; Mitchell, JR | 1 |
| Baumgartner, HR | 1 |
| Dechavanne, M; Follea, G; Trzeciak, MC | 1 |
| Amorosi, EL; Karpatkin, S | 1 |
| Bozdech, MJ; Crowell, EB; Eckel, RH; Waterhouse, BE | 1 |
| Vera, JC | 1 |
| Beck, R; Cornell, CJ; Smith, RE; Stern, R | 1 |
| Rodvien, R; Salzman, EW | 1 |
| Blakely, JA | 1 |
| Burns, TS; Saunders, RN; Stelzer, MR; Waskawic, ER | 1 |
| Buchanan, M; Hirsh, J | 2 |
| Michaud, PA; Regli, F | 1 |
| Francey, I; Philp, RB; Warren, BA | 1 |
| Dalessio, DJ; Otis, S; Smith, R | 1 |
| Stormorken, H | 1 |
| Thomas, BH; Wong, LT; Zawidzka, Z | 1 |
| Dulp-Gollasch, I; Fernández B de Quirós, J; Hess, H | 1 |
| Loew, D | 1 |
| Deykin, D | 1 |
| Blümel, G; Fritsche, HM; Ketterl, R; Leimgruber, D | 1 |
| Gent, M; Genton, E; Harker, LA; Hirsh, J | 4 |
| Doub, NH; Doub, PH; Klimt, CR | 1 |
| Gallus, AS; Hirsh, J | 1 |
| Köhler, H | 1 |
| Fox, IH; Sinclair, DS | 2 |
| Diamond, HS; Meisel, AD | 1 |
| Essien, EM; Mustard, JF | 1 |
| Corn, M | 1 |
| Barnett, HJ; McDonald, JW; Stuart, RK | 1 |
| Cazenave, JP; Guccione, MA; Mustard, JF; Packham, MA | 1 |
| Gotshall, RA; Harker, LA | 1 |
| Kinlough-Rathbone, RL; Moore, S; Mustard, JF; Packham, MA | 1 |
| Weber, E | 1 |
| Dalessio, DJ | 1 |
| Arfors, KE; Bergqvist, D; Tangen, O | 1 |
| Gent, M; Genton, E; Hirsh, J | 1 |
| Galbraith, PA; Ledwich, JR; Michaels, L | 1 |
| Davies, H; Genton, E; Ppppas, G; Steele, P; Weily, H | 1 |
| Austin, J; Kalendovsky, Z; Steele, P | 1 |
| Kendall, MJ | 1 |
| Schwartz, SI; Swedenborg, J | 1 |
| Lewis, GP; Westwick, J | 1 |
| de Gaetano, G | 1 |
| Vermylen, J | 1 |
| Hattori, A | 1 |
| Aosaki, M; Hosoda, S; Iwade, K; Kimata, S | 1 |
| Easton, JD | 1 |
| Ferlito, S | 1 |
| Jafri, SM | 1 |
| Delahaye, JP; Sagnol, P | 1 |
| Battista, RN; Boucher, J; Bravo, G; Côté, R; Stachenko, SJ | 1 |
| Iida, N | 1 |
| Bauman, JE; Domoto, DT; Joist, JH | 1 |
| Anzalone, N; Baldereschi, M; Bonatti, ML; Candelise, L; Fratiglioni, L; Gandolfo, C; Inzitari, D; Mamoli, A; Prencipe, M; Rasura, M | 1 |
| Mathur, AK; Mittal, SR; Tandon, R | 1 |
| Buring, JE; Hennekens, CH | 1 |
| Copeland, JG; Goldman, S; Henderson, WG; Moritz, T; Sethi, GK; Zadina, K | 1 |
| Kienast, J; Verstraete, M | 1 |
| del Zoppo, GJ | 1 |
| Fuster, V; Stein, B | 1 |
| Burghardt, B; Cardell, M; Janero, DR; Lopez, R | 1 |
| Johnson, M; Makuch, R | 1 |
| Chesler, E; Copeland, J; Doherty, J; Goldman, S; Henderson, W; Moritz, T; Ovitt, T; Read, R; Sako, Y; Zadina, K | 1 |
| Shalaev, SV | 1 |
| Bélanger, GL; Lavallée, JP; Lenis, J; Ouellet, CA | 1 |
| Borhani, NO | 1 |
| Tomov, I | 1 |
| Gelman, JS; Mehta, J | 1 |
| Chamberlain, DA | 1 |
| Frishman, WH; Miller, KP | 1 |
| Bollinger, A | 1 |
| Catella, F; Ciabattoni, G; Filabozzi, P; Forni, L; Patrignani, P; Patrono, C; Pierucci, A; Pugliese, F; Segni, M; Simonetti, BM | 1 |
| Matsuda, T | 1 |
| Harker, LA | 2 |
| Bertele', V; Cerletti, C; de Gaetano, G | 1 |
| Ambler, J; Butler, KD; Butler, PA; Shand, RA; Wallis, RB | 1 |
| Goldman, M; McCollum, CN | 1 |
| Chesebro, JH; Fuster, V; Steele, PM | 1 |
| Liusov, VA; Savenkov, MP | 1 |
| Botindari, G; Catalano, I; Davì, G; Strano, A | 1 |
| Chalmers, TC; Pincus, MM; Reitman, D; Sacks, HS; Sze, PC | 1 |
| Cairns, JA | 1 |
| Bjornsson, TD; Hanson, SR; Harker, LA | 2 |
| Limet, R | 1 |
| Fuster, V; Hirsh, J; Salzman, E | 1 |
| Chediak, J; Hirsh, J; Lewis, D; Resnekov, L | 1 |
| Brown, BG; Chesebro, JH; Ekeström, S; Harker, LA; Henderson, AH; Jewitt, DE; Oliver, MF; Sleight, P; Verstraete, M | 1 |
| Głab-Kordecka, E | 1 |
| Böhm, R | 1 |
| Maekawa, T | 1 |
| Fujimoto, T; Yamazaki, H | 1 |
| Lecompte, T; Samama, M | 1 |
| David, JL | 1 |
| Cairns, JA; Myers, MG; Singer, J | 1 |
| Lemberg, L; Valladares, BK | 1 |
| Sautter, RD | 1 |
| Di Perri, T | 1 |
| Lijnen, P | 1 |
| Gallus, AS | 1 |
| Fields, WS; Gary, H; Grotta, JC; Lemak, NA; Vital, D | 1 |
| Sherry, S | 4 |
| Rühle, H | 1 |
| Cairns, JA; Finnie, KJ; Froggatt, GM; Gent, M; Holder, DA; Jablonsky, G; Kostuk, WJ; Melendez, LJ; Myers, MG; Singer, J | 1 |
| FitzGerald, GA; Pedersen, AK | 1 |
| Davies, JA | 1 |
| Toivanen, J; Viinikka, L; Ylikorkala, O | 1 |
| Catella, F; Ciabattoni, G; Davì, G; Filabozzi, P; Forni, L; Patrignani, P; Patrono, C; Pugliese, F | 1 |
| Cerletti, C | 1 |
| Jouve, R; Larrue, J | 1 |
| Hashimoto, N; Kholoussy, AM; Kumashiro, R; Matsumoto, T; Piotrowski, JJ | 1 |
| Capel, P | 1 |
| Grunwald, J; Haudenschild, CC | 1 |
| Guccione, MA; Jenkins, CS; Mustard, JF; Packham, MA | 1 |
| Evans, G; Mustard, JF | 1 |
| Bolan, JC; Glenn, CH; Hardison, MD; Mason, RG; Mohammad, SF; Morton, BD | 1 |
| Fox, IH; Gershon, SL | 1 |
| Graeme, ML; Sigg, EB; Simke, J | 1 |
| Douglas, AS | 1 |
| Andersen, LA; Gormsen, J | 1 |
| Lekas, N; Lysz, K; Morrell, R; Rosenberg, JC; Sell, T; Villalalva, A | 1 |
| Bove, LG | 1 |
| Didisheim, P; Fuster, V; Kazmier, FJ | 1 |
| Forbes, CD; Prentice, CR | 1 |
| Diamond, HS; Paolino, JS | 1 |
| Pulver, WH; Schönbaum, E; Taichman, NS; Tsai, CC | 1 |
| Kersley, GD | 1 |
| Millikan, CH | 1 |
| Bluestone, R; Campion, D; Klinenberg, JR; Whitehouse, M | 1 |
| Diamond, HS; Sharon, E | 1 |
| Born, GV | 1 |
| Mason, RG; Read, MS; Saba, SR; Shermer, RW | 1 |
| Bluestone, R; Kippen, I; Klinenberg, JR | 1 |
| Bluestone, R; Kippen, I; Klinenberg, JR; Whitehouse, M | 1 |
| Peterson, J; Zucker, MB | 1 |
| Bluestone, R; Kippen, I; Klinenberg, JR; Whitehouse, MW | 1 |
| Masuda, Y; Nakamura, H; Nakamura, K; Soji, Y | 1 |
| Latham, BA; Radcliff, F; Robinson, RG | 1 |
| Graeme, ML; John, M; Sigg, EB | 1 |
| Braunwald, E | 1 |
| Newland, HR | 1 |
| Ritter, JM | 1 |
| Staiger, C; Walter, E | 1 |
| Boissel, JP; Faucomprez, C; Leizorovicz, A | 1 |
| McNicol, GP | 1 |
| Genton, E | 1 |
| Schröder, R | 1 |
| Perrenoud, JJ | 1 |
| Kallio, V | 1 |
| Marshall, AJ | 1 |
| de Bono, DP | 1 |
| Breddin, K; Loew, D; Uberla, K | 1 |
| Gross, F | 1 |
| Bertelè, V; Cerletti, C; de Gaetano, G | 1 |
| Friedewald, WT; Schoenberger, JA | 1 |
| Adachi, K; Toshima, H | 1 |
| Spann, JF | 1 |
| Kelton, JG | 1 |
| Offerhaus, L | 1 |
| Chodorowski, Z | 1 |
| Dalen, JE; Goldberg, RJ; Gore, JM; Struckus, J | 1 |
| Agostoni, A | 1 |
| Hirsh, J; Kelton, JG | 1 |
| Bolte, HD | 2 |
| Bukowski, RM; Groppe, CW; Hewlett, JS; Livingston, RB; Reimer, RR; Weick, JK | 1 |
| Hinton, RC | 1 |
| Tullio, D | 1 |
| Bettmann, MA; Garnic, JD; Murray, PD | 1 |
| Buckler, P; Douglas, AS | 1 |
| Webster, J | 1 |
| Thiele, R | 1 |
| FitzGerald, GA; Sherry, S | 1 |
| Butt, R; de Boer, AC; Gent, M; Genton, E; Han, P; Turpie, AG | 1 |
| Guiraud-Chaumeil, B | 1 |
| Faxon, DP; Haudenschild, CC; Ryan, TJ; Sanborn, TA | 1 |
| Carter, WJ; Liem, PH; Wilkerson, RJ | 1 |
| Kester, RC | 1 |
| Birgens, HS; Hansen, MS | 2 |
| Hashimoto, H; Ogawa, K | 1 |
| Gaillard, JL; Kher, A; Lecompte, T; Samama, M | 1 |
| Bogousslavsky, J; Regli, F; Rousselle, J; Schmidt, PM | 1 |
| Bousser, MG | 2 |
| Mehta, J | 1 |
| Stamler, J | 1 |
| Bertha, G; Lechner, H; Ott, E | 1 |
| Chen, HM; Koch, EL; Larson, DE; Mazza, JJ; Milbauer, JP; Myers, WO; Plotka, ED; Ray, JR; Sautter, RD; Treuhaft, PS | 1 |
| Ramirez-Lassepas, M | 1 |
| Eichner, ER | 1 |
| Ordinas, A | 1 |
| Dworski, R; Musiał, J; Szczeklik, A | 1 |
| Gitler, B; Gitler, ES | 1 |
| Block, LH; Rhyner, K; Stenger, M | 1 |
| Lewis, GP; Smith, JR | 1 |
| Kaliman, J; Sinzinger, H; Strobl-Jäger, E | 1 |
| Beard, OW; Cain, TD; Wood, JS | 1 |
| Crow, MJ; Kester, RC; McCollum, CN; Rajah, SM | 1 |
| Butler, KD; White, AM | 1 |
| Buchanan, MR; Endrenyi, L; Giles, AR; Rosenfeld, J | 1 |
| Gent, M; Sackett, DL; Taylor, DW | 1 |
| Bouchier-Hayes, D | 1 |
| Nair, CK; Pagano, T; Sketch, MH | 1 |
| O'Flaherty, JT; Stimler, NP | 1 |
| Easton, JD; Hart, RG; Kaste, M; Sherman, DG | 1 |
| Saavedra, JC; Vergara, F | 1 |
| Mannucci, PM | 1 |
| Ritchie, JL; Stratton, JR | 1 |
| Van Aken, WG | 1 |
| Verdecchia, P | 2 |
| Barajas, L; Chen, AF; Morin, RJ; Moss, RA; Narayanan, AS; Raye, C; Srikantaiah, MV | 1 |
| Cortellaro, M; Polli, EE | 1 |
| Hampton, JR | 1 |
| Chelapurath, A; Essers, U; Häussinger, G; Pfennigs, H; Reul, H | 1 |
| Cerletti, C; de Gaetano, G; Livio, M; Rajtar, G | 1 |
| Badenhorst, PN; Deckmyn, H; Vermylen, J | 1 |
| Burg, J; Gaudiani, VA; Jamieson, SW; Kosek, JC; Miller, DC | 1 |
| Kazmier, FJ | 1 |
| Deck, JH; Kelton, JG; Littlejohn, GO; Reynolds, WJ | 1 |
| Innis, JD; Wenzel, DG | 1 |
| Brass, LF; Shattil, SJ | 1 |
| Held, K | 1 |
| Beamish, RE; Dhalla, NS; Karmazyn, M; Moffat, MP | 1 |
| Poliwoda, H | 1 |
| Whisnant, JP | 1 |
| Kaess, H; Sauerbruch, T | 1 |
| Jones, RJ | 1 |
| Margulies, EH; Sherry, S; White, AM | 1 |
| Friedman, LM | 1 |
| Bunting, S; Moncada, S; O'Grady, J | 1 |
| Breddin, K; Lechner, K; Loew, D; Uberla, K; Walter, E | 1 |
| Chesebro, JH; Fuster, V | 3 |
| Straub, PW | 1 |
| Kanazawa, T; Matsuoka, H | 1 |
| Sternon, J | 1 |
| Loogen, F; Misera, R; Reimers, HJ; Schneider, W | 1 |
| Sloan, RW | 1 |
| Cristol, R | 1 |
| Turpie, AG | 2 |
| Prentice, CR | 1 |
| Warlow, CP | 1 |
| Castaldi, PA | 1 |
| Boissel, JP; Destors, JM; Gillet, J; Leizorovicz, A; Schbath, J | 1 |
| Mehta, JL | 1 |
| Schöndorf, TH | 1 |
| Meloche, JP | 1 |
| Laiwah, AC | 1 |
| Boeynaems, JM | 1 |
| Marquardsen, J; Sørensen, PS | 1 |
| Goderová, Z; Kristan, M; Pstruzinová, H | 1 |
| Agnelli, G; Ballatori, E; Merante, F; Nenci, GG; Parise, P | 1 |
| Clark, WF; Moriarity, TA; Reid, BD; Tevaarwerk, GJ | 1 |
| Deuel, T; Gardner, F; Peck, WA | 1 |
| Cornu, P; Gratwohl, A; Richner, J; Speck, B | 1 |
| Frankel, AE; Rubenstein, MD; Wall, RT | 1 |
| Aubert, D; Ferrand, C; Loubrie, JC; Tuong, A; Tuong, CC | 1 |
| Koltai, M; Leprán, I; Szekeres, L | 1 |
| Bonow, RO; Capurro, N; Davenport, N; Epstein, SE; Goldstein, RE; Lipson, LC; Shulman, NR | 1 |
| Hamilton, GW; Harker, LA; Huang, TW; Ritchie, JL; Stratton, JR; Thiele, B; Warrick, LN | 1 |
| Byer, JA; Easton, JD | 1 |
| Lorenz, R; Siess, W; Weber, PC | 1 |
| Donner, L | 1 |
| Ali, M; Cooper, JD; Duffin, J; Klement, P; Masterson, J; McDonald, JW; Thiesson, JJ; Townsend, ER | 1 |
| Butler, KD; Smith, JR | 1 |
| Almirall, L; Borruel, MT; Escolar, G; Hernández, MR; Villaverde, CA | 1 |
| Rainwater, J; Steele, P | 1 |
| Blombäck, M; Mettinger, KL | 1 |
| Kahn, SB | 1 |
| Horwitz, DL | 1 |
| Culliton, BJ; Waterfall, WK | 1 |
| Czerniawska-Mysik, G; Nizankowska, E; Szczeklik, A | 1 |
| Ali, M; Cerskus, AL; McDonald, JW | 1 |
| Dahinden, C; Fehr, J | 1 |
| Faergeman, O | 1 |
| Paredero Del Bosque Martin, V | 1 |
| Croveri, G | 1 |
| Hayes, AH | 1 |
| Copeland, J; Goldman, S; Henderson, WG; Moritz, T; Sethi, G | 1 |
| Dalen, JE; Goldman, S; Stein, PD; Théroux, P | 1 |
| LECLERCQ, R; LISIN, N | 1 |
| AKAOKA, I; ITO, H; KOYAMA, S; OKAZAKI, M | 1 |
| CARCASSONNE, Y | 1 |
| KUNIN, CM | 1 |
108 review(s) available for aspirin and sulfinpyrazone
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
[Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Analgesics; Anti-Inflammatory Agents; Arteriosclerosis; Aspirin; Blood Coagulation; Blood Platelets; Cardiovascular Diseases; Dipyridamole; Dose-Response Relationship, Drug; Fibrinolytic Agents; Humans; In Vitro Techniques; Indomethacin; Oxyphenbutazone; Phenylbutazone; Platelet Adhesiveness; Platelet Aggregation; Sulfinpyrazone; Thromboembolism; Time Factors | 1976 |
[Inhibition of blood platelet function].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antimalarials; Aspirin; Chloroquine; Dipyridamole; Female; Humans; Maternal-Fetal Exchange; Platelet Aggregation; Pregnancy; Sulfinpyrazone; Vasodilator Agents | 1979 |
Role of blood platelets in coronary artery disease.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Aspirin; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Double-Blind Method; Drug Evaluation; Humans; Myocardial Infarction; Placebos; Platelet Aggregation; Prostaglandins, Synthetic; Spasm; Sulfinpyrazone | 1979 |
The role of platelets in glomerulonephritis.
Topics: Adenosine; Antidepressive Agents; Aspirin; Blood Platelets; Complement System Proteins; Endothelium; Glomerulonephritis; Hemostasis; Heparin; Histamine H1 Antagonists; Humans; Immunity; Immunoglobulins; Indomethacin; Kidney Diseases; Meclofenamic Acid; Mopidamol; Phagocytosis; Phenylbutazone; Platelet Aggregation; Prostaglandins; Pyrimidines; Sulfinpyrazone; Tranquilizing Agents; Warfarin | 1975 |
Clinical pharmacology of platelets.
Topics: Adenosine Diphosphate; Aspirin; Blood Coagulation; Blood Platelets; Cell Membrane; Clofibrate; Cyproheptadine; Dipyridamole; Drug Therapy, Combination; Furosemide; Halofenate; Heparin; Humans; Hydrocortisone; Hydroxychloroquine; Methylprednisolone; Penicillin G; Platelet Aggregation; Propranolol; Prostaglandins; Sulfinpyrazone; Vitamin E | 1977 |
[Prevention of thrombosis with coumarin, low doses of heparin, dextran and inhibitors of platelet function].
Topics: Aspirin; Coumarins; Dextrans; Dipyridamole; Heart Valve Prosthesis; Heparin; Humans; Lipids; Platelet Aggregation; Postoperative Care; Preoperative Care; Sulfinpyrazone; Thrombosis; Xanthinol Niacinate | 1977 |
Actions and clinical status of platelet-suppressive agents.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Sulfinpyrazone; Thrombosis | 1978 |
Platelet function inhibitors: their clinical use.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Platelet Aggregation; Renal Dialysis; Sulfinpyrazone; Thromboembolism | 1978 |
[Indications and uncertainties of antiaggregating agents].
Topics: Anticoagulants; Aspirin; Clofibrate; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone; Thromboembolism; Thrombophlebitis | 1977 |
Platelet suppressive therapy.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Sulfinpyrazone; Thrombophlebitis; Thrombosis | 1978 |
Platelets and thrombosis in the development of atherosclerosis and its complications.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Dipyridamole; Endothelium; Humans; Hyperlipidemias; Lipids; Rabbits; Sulfinpyrazone; Thrombosis | 1978 |
[Clinical application and evaluation of anti-platelet agents].
Topics: Aged; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Evaluation; Female; Humans; Intracranial Embolism and Thrombosis; Male; Myocardial Infarction; Prostheses and Implants; Sulfinpyrazone; Thrombophlebitis | 1978 |
Recent therapeutic advances in thrombotic thrombocytopenic purpura.
Topics: Adolescent; Adult; Aspirin; Blood Transfusion; Dextrans; Dipyridamole; Exchange Transfusion, Whole Blood; Female; Glucocorticoids; Humans; Male; Plasma; Plasmapheresis; Platelet Aggregation; Purpura, Thrombotic Thrombocytopenic; Splenectomy; Sulfinpyrazone | 1979 |
The pathophysiology of transient cerebral ischemic attacks.
Topics: Arteriosclerosis; Aspirin; Carotid Arteries; Cerebrovascular Disorders; Cholesterol; Embolism; Endocarditis; Female; Heart Diseases; Heart Neoplasms; Humans; Hypotension, Orthostatic; Ischemic Attack, Transient; Male; Myxoma; Platelet Aggregation; Prognosis; Retinal Artery; Sex Factors; Sulfinpyrazone; Thrombocytosis | 1979 |
Antiplatelet drugs in thromboembolism.
Topics: Anticoagulants; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Heart Valve Prosthesis; Humans; Sulfinpyrazone; Thromboembolism; Thrombophlebitis | 1979 |
Platelet inhibitors in the treatment of thrombosis.
Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Double-Blind Method; Female; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Ischemic Attack, Transient; Male; Middle Aged; Postoperative Complications; Random Allocation; Sulfinpyrazone; Thromboembolism; Thrombosis | 1978 |
[Treatment with antiplatelet drugs. Current status of knowledge].
Topics: Aspirin; Blood Platelet Disorders; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dextrans; Dipyridamole; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Platelet Aggregation; Postoperative Complications; Sulfinpyrazone; Thromboembolism | 1979 |
[Clinical prevention of thrombosis by antiplatelet agents].
Topics: Aspirin; Blood Platelets; Clofibrate; Dipyridamole; Humans; Hydroxychloroquine; Sulfinpyrazone; Thrombosis | 1979 |
[State of thrombosis risk: diagnostic and preventive possibilities].
Topics: Anticoagulants; Aspirin; Dipyridamole; Humans; Platelet Aggregation; Risk; Sulfinpyrazone; Thrombosis | 1979 |
[Prophylactic value of platelet anti-aggregants in coronary disease].
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Embolism; Heart Valve Prosthesis; Humans; Myocardial Infarction; Platelet Aggregation; Postoperative Complications; Sulfinpyrazone | 1979 |
[Prospects of antiaggregant therapy in prevention of atherosclerosis].
Topics: Animals; Anti-Inflammatory Agents; Anticoagulants; Arteriosclerosis; Aspirin; Blood Coagulation Disorders; Dipyridamole; Epoprostenol; Humans; Hyperlipidemias; Indomethacin; Papaverine; Platelet Aggregation; Prostaglandins; Prostaglandins, Synthetic; Sulfinpyrazone; Xanthines | 1979 |
Antiplatelet agents: a review.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Female; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Male; Myocardial Infarction; Postoperative Complications; Sulfinpyrazone; Thromboembolism | 1979 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Drug Combinations; Female; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Kidney Diseases; Kidneys, Artificial; Male; Silicone Elastomers; Sulfinpyrazone; Thromboembolism; Thrombosis; Vascular Diseases | 1975 |
Clinical trials in thrombosis: secondary prevention of myocardial infarction.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Female; Humans; Male; Myocardial Infarction; Prospective Studies; Sulfinpyrazone; Thromboembolism | 1976 |
Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Brain; Clofibrate; Dextrans; Dipyridamole; Humans; Ischemia; Kidney Diseases; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Serotonin Antagonists; Sulfinpyrazone; Sympathomimetics; Thrombosis | 1976 |
Antithrombotic drugs: part II.
Topics: Anabolic Agents; Ancrod; Animals; Aspirin; Blood Platelets; Clofibrate; Dextrans; Dipyridamole; Fibrinolytic Agents; Humans; Hydroxychloroquine; Myocardial Infarction; Plasminogen Activators; Streptokinase; Sulfinpyrazone; Thromboembolism; Thrombophlebitis; Urokinase-Type Plasminogen Activator | 1976 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Topics: Animals; Antidepressive Agents, Tricyclic; Aspirin; Blindness; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Male; Prospective Studies; Pyrimidines; Retrospective Studies; Sulfinpyrazone; Thromboembolism; Warfarin | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Graft Rejection; Humans; Kidney Transplantation; Male; Myocardial Infarction; Sulfinpyrazone; Thromboembolism; Thrombosis; Transplantation, Homologous | 1975 |
Antiplatelet therapy in the prevention of stroke.
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Sulfinpyrazone; Ticlopidine | 1991 |
[Platelet antiaggregants in the treatment of arterial thrombosis].
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Cerebrovascular Disorders; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Follow-Up Studies; Heart Valve Prosthesis; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Sulfinpyrazone; Thrombosis | 1991 |
Antiplatelet and anticoagulant therapy in acute myocardial infarction.
Topics: Aspirin; Dipyridamole; Heparin; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Sulfinpyrazone; Warfarin | 1991 |
[Anticoagulant or antiplatelet aggregation treatment after aortocoronary bypass].
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascular; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Sulfinpyrazone; Ticlopidine; Vitamin K | 1991 |
Aspirin in transient ischemic attacks and minor stroke: a meta-analysis.
Topics: Adult; Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Male; Meta-Analysis as Topic; Middle Aged; Randomized Controlled Trials as Topic; Sulfinpyrazone | 1991 |
[Study Group: "Evaluation of the efficacy of therapeutic treatments in cerebrovascular diseases"].
Topics: Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Double-Blind Method; Female; Follow-Up Studies; Humans; Ischemic Attack, Transient; Male; Middle Aged; Prognosis; Sulfinpyrazone | 1990 |
Pharmacology of the interaction between platelets and vessel wall.
Topics: Animals; Aspirin; Blood Platelets; Blood Vessels; Dextrans; Diltiazem; Dipyridamole; Epoprostenol; Humans; Imidazoles; Ketanserin; Piperidines; Pyrazoles; Pyrazolones; Sulfinpyrazone; Sulfonamides; Thiophenes; Ticlopidine | 1986 |
Antiplatelet therapy in thrombotic thrombocytopenic purpura.
Topics: Aspirin; Blood Platelets; Dextrans; Dipyridamole; Epoprostenol; Humans; Microcirculation; Platelet Aggregation; Purpura, Thrombotic Thrombocytopenic; Sulfinpyrazone; Ticlopidine | 1987 |
Role of platelet inhibitor therapy in myocardial infarction.
Topics: Aspirin; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Sulfinpyrazone | 1989 |
Issues in planning and interpreting active control equivalence studies.
Topics: Adult; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Humans; Random Allocation; Research Design; Sulfinpyrazone; Ticlopidine | 1989 |
[Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
Topics: Aspirin; Canada; Clinical Trials as Topic; Coronary Disease; Coronary Thrombosis; Dipyridamole; Drug Evaluation; Humans; Multicenter Studies as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Sulfinpyrazone; United States | 1989 |
Secondary prevention of coronary events after myocardial infarction. Beta-blockers and/or anti-platelets: to whom, when and for how long. A review.
Topics: Adrenergic beta-Antagonists; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Humans; Myocardial Infarction; Sulfinpyrazone | 1985 |
Platelets and prostaglandins in sudden death: therapeutic implications.
Topics: Adrenergic beta-Antagonists; Animals; Arachidonic Acid; Arachidonic Acids; Arteriosclerosis; Aspirin; Blood Platelets; Coronary Disease; Death, Sudden; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation; Prostaglandins; Risk; Sulfinpyrazone; Thrombosis | 1985 |
Platelets and antiplatelet therapy in ischemic heart disease.
Topics: Angina Pectoris; Angioplasty, Balloon; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Cyclooxygenase Inhibitors; Dipyridamole; Epoprostenol; Humans; Myocardial Infarction; Platelet Adhesiveness; Sulfinpyrazone; Thromboxanes | 1986 |
Drugs, prostaglandins, and renal function.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Aspirin; Cyclooxygenase Inhibitors; Diuretics; Humans; Kidney; Pharmaceutical Preparations; Prostaglandins; Sulfinpyrazone; Sulindac; Thromboxane-A Synthase | 1985 |
[Hypercoagulability and cerebral infarction].
Topics: Aspirin; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Cerebral Infarction; Clinical Trials as Topic; Dipyridamole; Glycoproteins; Humans; Platelet Aggregation; Sulfinpyrazone; Suloctidil; Thromboxanes; von Willebrand Factor | 1986 |
Antiplatelet drugs in the management of patients with thrombotic disorders.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Blood Coagulation Disorders; Blood Platelets; Catheterization; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Glomerulonephritis; Humans; Sulfinpyrazone; Suloctidil; Thiophenes; Thrombophlebitis; Thrombosis; Ticlopidine; Vascular Diseases; Vascular Surgical Procedures | 1986 |
[Antiplatelet drugs and prevention of aortocoronary bypass occlusion].
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Sulfinpyrazone; Thrombosis; Ticlopidine | 1988 |
Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Follow-Up Studies; Humans; Male; Myocardial Infarction; Random Allocation; Sulfinpyrazone | 1987 |
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cardiovascular Diseases; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Female; Glomerulonephritis; Graft Occlusion, Vascular; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Postoperative Complications; Random Allocation; Sulfinpyrazone; Thiophenes; Ticlopidine | 1986 |
Dose antiplatelet agents; the relationship among side effects, and antithrombotic effectiveness.
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Dipyridamole; Dose-Response Relationship, Drug; Epoprostenol; Fibrinolytic Agents; Gastric Mucosa; Humans; Sulfinpyrazone | 1986 |
Antithrombotic agents in coronary artery disease.
Topics: Angina, Unstable; Anticoagulants; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction; Sulfinpyrazone; Thromboembolism; Time Factors | 1986 |
[Thrombocyte aggregation inhibitors--a new class of active substances. 2. Chemical and pharmacologic aspects of some agents].
Topics: Anti-Inflammatory Agents; Aspirin; Chemical Phenomena; Chemistry; Dipyridamole; Heterocyclic Compounds; Humans; Imidazoles; Phthalazines; Platelet Aggregation; Pyridazines; Pyridines; Pyrimidines; Quinazolines; Quinolines; Sulfinpyrazone | 1986 |
[Antiplatelet therapy of thrombosis].
Topics: Animals; Aspirin; Cerebrovascular Disorders; Coronary Disease; Humans; Postoperative Complications; Sulfinpyrazone; Thrombosis | 1986 |
[Thrombosis in various diseases: arteriosclerosis and thrombosis].
Topics: Animals; Arteriosclerosis; Aspirin; Dipyridamole; Humans; Sulfinpyrazone; Thrombosis | 1986 |
Aspirin and other platelet-aggregation inhibiting drugs.
Topics: Aspirin; Blood Platelets; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Female; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Kinetics; Male; Platelet Aggregation; Sulfinpyrazone; Thrombophlebitis | 1985 |
Does platelet antiaggregant therapy lessen the severity of stroke?
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Double-Blind Method; Humans; Ischemic Attack, Transient; Platelet Aggregation; Prospective Studies; Random Allocation; Sulfinpyrazone | 1985 |
Clinical aspects of antiplatelet therapy.
Topics: Angina Pectoris; Aspirin; Blood Coagulation Disorders; Clinical Trials as Topic; Dipyridamole; Female; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone; Thromboembolism | 1985 |
[Controversy on platelet-inhibiting drugs].
Topics: Angina, Unstable; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Artery Bypass; Double-Blind Method; Female; Humans; Male; Postoperative Care; Random Allocation; Sulfinpyrazone | 1985 |
The human pharmacology of platelet inhibition: pharmacokinetics relevant to drug action.
Topics: Aspirin; Blood Platelets; Dipyridamole; Dose-Response Relationship, Drug; Fibrinolytic Agents; Humans; Kinetics; Models, Biological; Sulfinpyrazone; Thromboxane-A Synthase | 1985 |
Clinical pharmacology of platelet cyclooxygenase inhibition.
Topics: Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Epoprostenol; Fibrinolytic Agents; Humans; Sulfinpyrazone; Sulindac; Thromboxane B2; Time Factors | 1985 |
Management of thrombotic diseases.
Topics: Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Coumarins; Dextrans; Dipyridamole; Drug Antagonism; Drug Hypersensitivity; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Heart Valve Prosthesis; Hemorrhage; Heparin; Histamine H1 Antagonists; Humans; Hydrocortisone; Indenes; Intracranial Embolism and Thrombosis; Iodine Isotopes; Platelet Adhesiveness; Prostaglandins; Reserpine; Rheumatic Heart Disease; Streptokinase; Sulfinpyrazone; Thrombosis | 1971 |
The prevention of thrombosis.
Topics: Anti-Inflammatory Agents; Anticoagulants; Aspirin; Coumarins; Dipyridamole; Heparin; Humans; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1974 |
Platelet inhibition in the management of thrombosis.
Topics: Aspirin; Blindness; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Dextrans; Dipyridamole; Fibrinogen; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Iodine Radioisotopes; Molecular Weight; Myocardial Infarction; Phlebography; Renal Dialysis; Sulfinpyrazone; Thromboembolism; Thrombophlebitis; Thrombosis | 1974 |
Anticoagulants.
Topics: Anticoagulants; Aspirin; Blood Platelet Disorders; Dipyridamole; Enzyme Therapy; Factor IX; Factor VII; Factor X; Hemolysin Proteins; Hemorrhage; Heparin; Heparin Antagonists; Humans; Infusions, Parenteral; Phenindione; Protamines; Prothrombin; Streptokinase; Sulfinpyrazone; Thrombophlebitis; Thrombosis; Venoms; Warfarin | 1974 |
Platelet pharmacology in relation to thrombosis.
Topics: Adenine Nucleotides; Animals; Arteriosclerosis; Aspirin; Binding Sites; Blood Cells; Blood Coagulation; Blood Platelet Disorders; Blood Platelets; Coronary Vessels; Humans; Methods; Nucleosides; Platelet Adhesiveness; Rabbits; Rats; Salts; Sulfinpyrazone; Thrombosis | 1970 |
Cardiac death prevention in post-myocardial infarction patients: a review.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Animals; Anti-Arrhythmia Agents; Anticoagulants; Arrhythmias, Cardiac; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Disease; Coronary Vessels; Death, Sudden; Disease Models, Animal; Dogs; Estrogens; Female; Follow-Up Studies; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Recurrence; Sulfinpyrazone; Ventricular Fibrillation | 1980 |
[Secondary prevention following myocardial infarct. Platelet aggregation inhibitors, beta receptor blockers, antiarrhythmics].
Topics: Adrenergic beta-Antagonists; Alprenolol; Anti-Arrhythmia Agents; Aspirin; Dipyridamole; Female; Fibrinolytic Agents; Humans; Male; Myocardial Infarction; Phenprocoumon; Platelet Aggregation; Practolol; Propranolol; Recurrence; Sex Factors; Sulfinpyrazone; Time Factors | 1981 |
Drug therapy of hypertension and ischaemic heart disease.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Antihypertensive Agents; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Diuretics; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Sulfinpyrazone | 1981 |
[Prevention of myocardial infarction by chemotherapy].
Topics: Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Blood Platelets; Dipyridamole; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Recurrence; Sulfinpyrazone | 1982 |
Changing concepts of pathophysiology, prognosis, and therapy in acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aspirin; Coronary Disease; Coronary Vasospasm; Death, Sudden; Dipyridamole; Humans; Monitoring, Physiologic; Myocardial Infarction; Prognosis; Recurrence; Sulfinpyrazone | 1983 |
Antiplatelet agents: rationale and results.
Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Animals; Arachidonic Acids; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cerebrovascular Disorders; Collagen; Coronary Disease; Dipyridamole; Female; Heart Valve Prosthesis; Hemostasis; Humans; Intracranial Embolism and Thrombosis; Male; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Sex Factors; Sulfinpyrazone; Thrombosis | 1983 |
[Perspectives of the preventive treatment of patients after myocardial infarction].
Topics: Adrenergic beta-Antagonists; Aspirin; Coronary Disease; Death, Sudden; Exercise Therapy; Humans; Myocardial Infarction; Sulfinpyrazone | 1984 |
Bleeding associated with antithrombotic therapy.
Topics: 4-Hydroxycoumarins; Aspirin; Dextrans; Dipyridamole; Dose-Response Relationship, Drug; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Myocardial Infarction; Risk; Streptodornase and Streptokinase; Sulfinpyrazone; Thrombocytopenia; Thrombosis | 1980 |
Therapy of thrombotic thrombocytopenic purpura: an overview.
Topics: Adrenal Cortex Hormones; Aspirin; Blood Transfusion; Dextrans; Dipyridamole; Humans; Immunosuppressive Agents; Plasmapheresis; Purpura, Thrombotic Thrombocytopenic; Renal Dialysis; Retrospective Studies; Splenectomy; Sulfinpyrazone | 1981 |
[Role of antiaggregant platelet drugs in thromboembolism].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anti-Bacterial Agents; Aspirin; Cerebrovascular Disorders; Dextrans; Dipyridamole; Humans; Mitral Valve; Platelet Aggregation; Platelet Function Tests; Pyridines; Pyridinolcarbamate; Random Allocation; Sulfinpyrazone; Suloctidil; Thiophenes; Thromboembolism; Ticlopidine | 1981 |
Pharmacology and pharmacokinetics of platelet-active drugs under current clinical investigation.
Topics: Absorption; Animals; Aspirin; Biotransformation; Blood Platelets; Cyclooxygenase Inhibitors; Dipyridamole; Humans; Kinetics; Prostaglandins; Structure-Activity Relationship; Sulfinpyrazone | 1982 |
Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Double-Blind Method; Humans; Myocardial Infarction; Postoperative Complications; Sulfinpyrazone; Thromboembolism | 1982 |
Current therapy of cerebrovascular disease.
Topics: Adult; Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Risk; Sulfinpyrazone | 1984 |
Pharmacology of platelet-affecting drugs.
Topics: Animals; Arachidonic Acids; Arteriosclerosis; Aspirin; Blood Platelets; Cyclic AMP; Dose-Response Relationship, Drug; Female; Heparin; Humans; Indomethacin; Male; Papio; Phospholipases; Platelet Adhesiveness; Platelet Function Tests; Rabbits; Sulfinpyrazone; Thrombin; Thromboembolism; Thrombosis; Thromboxane-A Synthase; Vasoconstriction; Ventricular Fibrillation | 1980 |
[Pharmacology of anti-platelet agents].
Topics: Animals; Anticoagulants; Aspirin; Blood Platelets; Cyclic AMP; Cyclooxygenase Inhibitors; Dipyridamole; Epoprostenol; Female; Fibrinolytic Agents; Humans; In Vitro Techniques; Intestinal Absorption; Kinetics; Male; Papio; Platelet Aggregation; Prostaglandin Antagonists; Rabbits; Sulfinpyrazone; Thiophenes; Thrombosis; Thromboxane A2; Ticlopidine | 1983 |
[Place of antiplatelet agents in the prevention of cerebral ischemic strokes].
Topics: Anticoagulants; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone; Time Factors | 1983 |
Therapeutical aspects of cerebrovascular disease.
Topics: Aspirin; Blood Coagulation; Cerebrovascular Disorders; Clofibrate; Dipyridamole; Erythrocyte Aggregation; Erythrocytes; Humans; Ischemic Attack, Transient; Pentoxifylline; Plasma; Platelet Aggregation; Sulfinpyrazone | 1983 |
Role of platelet-active drugs in coronary artery disease.
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Europe; Female; Humans; Male; Myocardial Infarction; Prospective Studies; Research Design; Sulfinpyrazone; Time Factors; United States | 1983 |
Platelet inhibitors for TIAs. A review of prospective drug trial results.
Topics: Aged; Aspirin; Clofibrate; Dipyridamole; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Male; Platelet Aggregation; Prospective Studies; Recurrence; Sulfinpyrazone | 1984 |
Platelets, carotids, and coronaries. Critique on antithrombotic role of antiplatelet agents, exercise, and certain diets.
Topics: Angina Pectoris; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Carotid Artery Thrombosis; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Endothelium; Exercise Therapy; Female; Humans; Ischemic Attack, Transient; Life Style; Male; Platelet Aggregation; Sex Factors; Sulfinpyrazone | 1984 |
[Current clinical results of antiplatelet medication].
Topics: Animals; Anticoagulants; Aspirin; Blood Platelets; Brain Ischemia; Coronary Disease; Dipyridamole; Drug Evaluation; Heart Valve Prosthesis; Humans; Myocardial Infarction; Platelet Aggregation; Platelet Function Tests; Postoperative Complications; Rabbits; Sulfinpyrazone; Thromboembolism; Thrombophlebitis; Vascular Surgical Procedures | 1984 |
[Blood platelets and myocardial infarction].
Topics: Aspirin; Blood Platelets; Dipyridamole; Epoprostenol; Humans; Myocardial Infarction; Platelet Aggregation; Prostaglandins, Synthetic; Sulfinpyrazone; Thromboxane A2 | 1984 |
Efficacy of antiplatelet drugs in the maintenance of aortocoronary vein bypass graft patency.
Topics: Animals; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Cyclooxygenase Inhibitors; Dipyridamole; Humans; Saphenous Vein; Sulfinpyrazone | 1983 |
Medical Grand Rounds: extracranial carotid artery disease.
Topics: Adolescent; Adult; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Auscultation; Carotid Artery Diseases; Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Sulfinpyrazone | 1980 |
Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
Topics: Animals; Anticoagulants; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Female; Humans; In Vitro Techniques; Male; Placebos; Platelet Adhesiveness; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1980 |
Presentation and analysis of the results of clinical trials in cardiovascular disease.
Topics: Aspirin; Clinical Trials as Topic; Disopyramide; Home Care Services; Hospitalization; Humans; Myocardial Infarction; Oxprenolol; Sulfinpyrazone | 1981 |
[Prevention of thrombosis by thrombocyte inhibition. 2. Clinical results].
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofibrate; Dextrans; Dipyridamole; Humans; Kidney Diseases; Sulfinpyrazone; Thrombosis | 1980 |
[Critical evaluation of the usefulness of drugs inhibiting platelet function in the prevention of postoperative deep venous thrombosis and in ischemic cardiopathy].
Topics: Anticoagulants; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Flurbiprofen; Humans; Hydroxychloroquine; Lidocaine; Platelet Aggregation; Postoperative Complications; Pulmonary Embolism; Sulfinpyrazone; Thromboembolism; Thrombophlebitis | 1980 |
Prostaglandins and platelets.
Topics: Arachidonic Acids; Aspirin; Blood Platelets; Epoprostenol; Fatty Acids; Humans; Oxygenases; Phospholipases A; Phospholipases A1; Platelet Adhesiveness; Platelet Aggregation; Prostaglandins; Sulfinpyrazone; Thrombosis; Thromboxane A2 | 1980 |
Sulfinpyrazone: a review of its pharmacological properties and therapeutic use.
Topics: Animals; Anti-Arrhythmia Agents; Antibody Formation; Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clinical Trials as Topic; Fibrinolytic Agents; Humans; Platelet Aggregation; Prostaglandins; Sulfinpyrazone; Thrombosis | 1980 |
Platelet-active drugs in the secondary prevention of cardiovascular events: an overview.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Coronary Disease; Dipyridamole; Sulfinpyrazone; Thrombophlebitis; Thrombosis | 1980 |
Antithrombotic drugs in relation to prostaglandin metabolism.
Topics: Aspirin; Coronary Disease; Dipyridamole; Extracorporeal Circulation; Fibrinolytic Agents; Heparin; Humans; Inuit; Platelet Aggregation; Prostaglandins; Sulfinpyrazone; Thromboembolism | 1980 |
Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
Topics: Adult; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Female; Humans; Male; Middle Aged; Myocardial Infarction; Sex Factors; Sulfinpyrazone | 1981 |
10. Antithrombotic therapy: role of platelet-inhibitor drugs. II. Pharmacologic effects of platelet-inhibitor drugs (second of three parts).
Topics: Aspirin; Dipyridamole; Drug Therapy, Combination; Epoprostenol; Fibrinolytic Agents; Gastrointestinal Diseases; Humans; Platelet Aggregation; Prostaglandins; Sulfinpyrazone; Thrombosis | 1981 |
[Myocardial infarct: secondary prevention with drugs and their effects].
Topics: Alprenolol; Aspirin; Dipyridamole; Humans; Myocardial Infarction; Prognosis; Sulfinpyrazone | 1980 |
[Platelet antiaggregants and arteriopathies].
Topics: Arterial Occlusive Diseases; Aspirin; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1981 |
Antiplatelet therapy.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Heart Valve Diseases; Humans; Sulfinpyrazone; Thrombophlebitis; Thrombosis | 1981 |
Myocardial infarction.
Topics: Anticoagulants; Aspirin; Blood Platelets; Death, Sudden; Dipyridamole; Fibrinolytic Agents; Humans; Myocardial Infarction; Sulfinpyrazone | 1981 |
Cerebrovascular disease.
Topics: Anticoagulants; Antifibrinolytic Agents; Aspirin; Blood Platelets; Cerebrovascular Disorders; Fibrinolytic Agents; Heart Valve Diseases; Humans; Intracranial Embolism and Thrombosis; Ischemic Attack, Transient; Subarachnoid Hemorrhage; Sulfinpyrazone; Thrombophlebitis; Tomography, X-Ray Computed | 1981 |
Antiplatelet agents: their role in the prevention of sudden death.
Topics: Animals; Aspirin; Blood Platelets; Cell Survival; Clinical Trials as Topic; Coronary Circulation; Coronary Disease; Death, Sudden; Dipyridamole; Dogs; Endothelium; Humans; Male; Muscle, Smooth; Myocardial Infarction; Papio; Platelet Adhesiveness; Prostaglandins; Rabbits; Sulfinpyrazone | 1982 |
[Platelets and prostaglandins in ischemic cardiopathy. Theoretical and practical aspects and research prospects].
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Humans; Platelet Aggregation; Platelet Count; Prostaglandins; Sulfinpyrazone; Thromboxanes | 1982 |
Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cell Division; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Heart Diseases; Humans; Hydroxychloroquine; Neoplasms; Sulfinpyrazone; Thromboembolism; Thrombosis | 1982 |
Use of cumulative meta-analysis in the design, monitoring, and final analysis of a clinical trial: a case study.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clinical Protocols; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Humans; Meta-Analysis as Topic; Placebos; Platelet Aggregation Inhibitors; Saphenous Vein; Sulfinpyrazone; Uricosuric Agents | 1995 |
97 trial(s) available for aspirin and sulfinpyrazone
| Article | Year |
|---|---|
Role of blood platelets in coronary artery disease.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Aspirin; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Double-Blind Method; Drug Evaluation; Humans; Myocardial Infarction; Placebos; Platelet Aggregation; Prostaglandins, Synthetic; Spasm; Sulfinpyrazone | 1979 |
[Possibilities and limits of controlled clinical therapy studies for the demonstration of the effectiveness of antithrombotic therapy].
Topics: Adult; Anticoagulants; Aspirin; Clinical Trials as Topic; Dextrans; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy; Early Ambulation; Exercise Therapy; Fibrinogen; Fibrinolysis; Heparin; Humans; Myocardial Infarction; Physical Therapy Modalities; Platelet Aggregation; Postoperative Complications; Posture; Pulmonary Embolism; Streptokinase; Sulfinpyrazone; Thromboembolism; Thrombosis | 1975 |
Internation Committee on Thrombosis and Haemostasis Basil, 8.-11. September 1974 Subcommittee on Clinical Investigations: Registry of prospective clinical trials.
Topics: Ancrod; Animals; Arterial Occlusive Diseases; Aspirin; Batroxobin; Clinical Trials as Topic; Fibrinolysin; Hematology; Heparin; Humans; Infant, Newborn; Myocardial Infarction; Plasminogen; Pulmonary Embolism; Registries; Research; Respiratory Distress Syndrome, Newborn; Streptokinase; Sulfinpyrazone; Swine; Thrombophlebitis; Urokinase-Type Plasminogen Activator | 1975 |
Effect of sulphinpyrazone and aspirin on latelet adhesion to activated charcoal and dialysis membranes in vitro.
Topics: Adult; Aspirin; Blood Coagulation Tests; Charcoal; Clinical Trials as Topic; Dialysis; Drug Synergism; Hemoperfusion; Humans; Male; Membranes, Artificial; Platelet Adhesiveness; Sulfinpyrazone | 1977 |
Drug therapy: antiplatelet therapy (second of two parts).
Topics: Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dextrans; Female; Heart Valve Prosthesis; Hemostasis; Humans; Male; Microcirculation; Middle Aged; Postoperative Complications; Sulfinpyrazone; Thromboembolism; Thrombophlebitis; Thrombosis | 1978 |
A randomized trial of aspirin and sulfinpyrazone in threatened stroke.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Ischemic Attack, Transient; Male; Prognosis; Risk; Sex Factors; Sulfinpyrazone; Time Factors | 1978 |
Preventing stroke.
Topics: Aspirin; Canada; Cerebrovascular Disorders; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Random Allocation; Sulfinpyrazone | 1978 |
The Canadian trial of aspirin and sulfinpyrazone in threatened stroke.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Female; Humans; Male; Research Design; Sulfinpyrazone | 1978 |
Guidelines for the management of transient ischemic attacks.
Topics: Anticoagulants; Aspirin; Blood Platelets; Carotid Arteries; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Endarterectomy; Humans; Ischemic Attack, Transient; Placebos; Sulfinpyrazone | 1978 |
Aspirin to prevent a stroke?
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Female; Humans; Ischemic Attack, Transient; Male; Sulfinpyrazone | 1978 |
[Clinical application and evaluation of anti-platelet agents].
Topics: Aged; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Evaluation; Female; Humans; Intracranial Embolism and Thrombosis; Male; Myocardial Infarction; Prostheses and Implants; Sulfinpyrazone; Thrombophlebitis | 1978 |
Controversy in neurology: the Canadian study on TIA and aspirin. A critique of the Canadian TIA study.
Topics: Aspirin; Canada; Clinical Trials as Topic; Double-Blind Method; Humans; Ischemic Attack, Transient; Male; Sulfinpyrazone | 1979 |
Controversy in neurology: the Canadian study on TIA and aspirin. A critique of the Canadian TIA study. Reply.
Topics: Aspirin; Canada; Clinical Trials as Topic; Double-Blind Method; Humans; Ischemic Attack, Transient; Male; Sulfinpyrazone | 1979 |
Controversy in the interpretation of clinical trials.
Topics: Aspirin; Canada; Clinical Trials as Topic; Double-Blind Method; Humans; Ischemic Attack, Transient; Male; Sulfinpyrazone | 1979 |
Platelet inhibitors in the treatment of thrombosis.
Topics: Adult; Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Double-Blind Method; Female; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Ischemic Attack, Transient; Male; Middle Aged; Postoperative Complications; Random Allocation; Sulfinpyrazone; Thromboembolism; Thrombosis | 1978 |
Does aspirin prevent stroke?
Topics: Anticoagulants; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Drug Interactions; Female; Health Promotion; Humans; Ischemic Attack, Transient; Male; Sulfinpyrazone | 1979 |
Prevention of death from myocardial infarction by aspirin and other platelet active drugs.
Topics: Aspirin; Clinical Trials as Topic; Humans; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone | 1979 |
The role of platelets in transient ischemic attacks and cerebral vascular accidents.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Female; Humans; Ischemic Attack, Transient; Male; Placebos; Sulfinpyrazone | 1978 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Drug Combinations; Female; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Kidney Diseases; Kidneys, Artificial; Male; Silicone Elastomers; Sulfinpyrazone; Thromboembolism; Thrombosis; Vascular Diseases | 1975 |
Clinical trials in thrombosis: secondary prevention of myocardial infarction.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Female; Humans; Male; Myocardial Infarction; Prospective Studies; Sulfinpyrazone; Thromboembolism | 1976 |
The effect of platelet function inhibitors on experimental venous thrombosis formation in rabbits.
Topics: Adenosine Diphosphate; Animals; Aspirin; Blood Platelets; Clinical Trials as Topic; Collagen; Dipyridamole; Female; Male; Platelet Adhesiveness; Platelet Aggregation; Rabbits; Sulfinpyrazone; Thrombophlebitis; Tromethamine | 1975 |
The current status of platelet suppressive drugs in the treatment of thrombosis.
Topics: Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cardiac Catheterization; Cell Survival; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Myocardial Infarction; Postoperative Complications; Renal Dialysis; Sulfinpyrazone; Thrombocytosis; Thromboembolism | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Topics: Animals; Antidepressive Agents, Tricyclic; Aspirin; Blindness; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Male; Prospective Studies; Pyrimidines; Retrospective Studies; Sulfinpyrazone; Thromboembolism; Warfarin | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Graft Rejection; Humans; Kidney Transplantation; Male; Myocardial Infarction; Sulfinpyrazone; Thromboembolism; Thrombosis; Transplantation, Homologous | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts).
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Clofibrate; Dipyridamole; Drug Evaluation; Fibrinolytic Agents; Humans; Hydroxychloroquine; Postoperative Complications; Pulmonary Embolism; Sulfinpyrazone; Thromboembolism; Thrombophlebitis; Thrombosis | 1975 |
Proceedings: A clinical trial of antiplatelet therapy in patients with coronary arterial disease.
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Disease; Humans; Sulfinpyrazone | 1975 |
[Anticoagulant or antiplatelet aggregation treatment after aortocoronary bypass].
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascular; Humans; Meta-Analysis as Topic; Platelet Aggregation Inhibitors; Sulfinpyrazone; Ticlopidine; Vitamin K | 1991 |
Combined aspirin and sulfinpyrazone in the prevention of recurrent hemodialysis vascular access thrombosis.
Topics: Aspirin; Blood Coagulation Tests; Blood Platelets; Catheters, Indwelling; Drug Evaluation; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Humans; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Recurrence; Renal Dialysis; Sulfinpyrazone; Thrombosis; Thromboxane B2 | 1991 |
[Study Group: "Evaluation of the efficacy of therapeutic treatments in cerebrovascular diseases"].
Topics: Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Double-Blind Method; Female; Follow-Up Studies; Humans; Ischemic Attack, Transient; Male; Middle Aged; Prognosis; Sulfinpyrazone | 1990 |
Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. Department of Veterans Affairs Cooperative Study on Antiplatelet Therapy.
Topics: Aspirin; Blood Transfusion; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Graft Occlusion, Vascular; Hemorrhage; Humans; Male; Middle Aged; Premedication; Randomized Controlled Trials as Topic; Reoperation; Sulfinpyrazone; Vascular Patency | 1990 |
Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Graft Occlusion, Vascular; Humans; Middle Aged; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Saphenous Vein; Sulfinpyrazone; Time Factors; Vascular Patency | 1989 |
[Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
Topics: Aspirin; Canada; Clinical Trials as Topic; Coronary Disease; Coronary Thrombosis; Dipyridamole; Drug Evaluation; Humans; Multicenter Studies as Topic; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Sulfinpyrazone; United States | 1989 |
Overview of completed sudden death trials: European experience.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Aspirin; Calcium Channel Blockers; Clinical Trials as Topic; Death, Sudden; Heart Diseases; Humans; Sulfinpyrazone | 1987 |
Platelets and antiplatelet therapy in ischemic heart disease.
Topics: Angina Pectoris; Angioplasty, Balloon; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Cyclooxygenase Inhibitors; Dipyridamole; Epoprostenol; Humans; Myocardial Infarction; Platelet Adhesiveness; Sulfinpyrazone; Thromboxanes | 1986 |
[Hypercoagulability and cerebral infarction].
Topics: Aspirin; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Cerebral Infarction; Clinical Trials as Topic; Dipyridamole; Glycoproteins; Humans; Platelet Aggregation; Sulfinpyrazone; Suloctidil; Thromboxanes; von Willebrand Factor | 1986 |
Mode of action of currently used antiplatelet drugs.
Topics: Aspirin; Blood Platelets; Blood Vessels; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Humans; Platelet Aggregation; Platelet Membrane Glycoproteins; Sulfinpyrazone; Ticlopidine | 1986 |
Platelet-inhibitory therapy in reconstructive arterial surgery.
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Graft Occlusion, Vascular; Humans; Sulfinpyrazone; Thrombosis | 1985 |
Antiplatelet agents in the secondary prevention of stroke: meta-analysis of the randomized control trials.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Drug Combinations; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Random Allocation; Sulfinpyrazone | 1988 |
Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Double-Blind Method; Follow-Up Studies; Humans; Male; Myocardial Infarction; Random Allocation; Sulfinpyrazone | 1987 |
Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
Topics: Anticoagulants; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Cardiovascular Diseases; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Female; Glomerulonephritis; Graft Occlusion, Vascular; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Postoperative Complications; Random Allocation; Sulfinpyrazone; Thiophenes; Ticlopidine | 1986 |
Dose antiplatelet agents; the relationship among side effects, and antithrombotic effectiveness.
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Dipyridamole; Dose-Response Relationship, Drug; Epoprostenol; Fibrinolytic Agents; Gastric Mucosa; Humans; Sulfinpyrazone | 1986 |
Antithrombotic agents in coronary artery disease.
Topics: Angina, Unstable; Anticoagulants; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction; Sulfinpyrazone; Thromboembolism; Time Factors | 1986 |
Evaluation of antiplatelet agents in the prevention of aorto-coronary bypass occlusion.
Topics: Administration, Oral; Anticoagulants; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fibrinolytic Agents; Graft Occlusion, Vascular; Heparin; Humans; Platelet Aggregation; Saphenous Vein; Sulfinpyrazone; Thiophenes; Ticlopidine | 1986 |
[Secondary prevention of ischemic heart disease. Evaluation of platelet function in patients treated with anticoagulants and cod liver oil].
Topics: Adult; Aged; Anticoagulants; Aspirin; Clinical Trials as Topic; Cod Liver Oil; Coronary Disease; Dipyridamole; Fish Oils; Humans; Middle Aged; Platelet Aggregation; Recurrence; Sulfinpyrazone | 1986 |
A critical appraisal of the clinical efficiency of anti-platelet drugs.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Double-Blind Method; Hemorrhage; Humans; Myocardial Revascularization; Prospective Studies; Sulfinpyrazone; Thromboxanes | 1986 |
Does platelet antiaggregant therapy lessen the severity of stroke?
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Double-Blind Method; Humans; Ischemic Attack, Transient; Platelet Aggregation; Prospective Studies; Random Allocation; Sulfinpyrazone | 1985 |
Clinical aspects of antiplatelet therapy.
Topics: Angina Pectoris; Aspirin; Blood Coagulation Disorders; Clinical Trials as Topic; Dipyridamole; Female; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone; Thromboembolism | 1985 |
[Controversy on platelet-inhibiting drugs].
Topics: Angina, Unstable; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Artery Bypass; Double-Blind Method; Female; Humans; Male; Postoperative Care; Random Allocation; Sulfinpyrazone | 1985 |
[Anticoagulants and thrombocyte aggregation inhibitors in or following myocardial infarct].
Topics: Anticoagulants; Aspirin; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Fibrinolytic Agents; Humans; Myocardial Infarction; Platelet Aggregation; Recurrence; Sulfinpyrazone | 1985 |
Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Random Allocation; Sulfinpyrazone | 1985 |
Secondary prevention of myocardial infarction.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Myocardial Infarction; Random Allocation; Sulfinpyrazone | 1985 |
[Eicosanoids, myocardial ischemia and sudden death].
Topics: Animals; Arrhythmias, Cardiac; Aspirin; Clinical Trials as Topic; Coronary Disease; Cyclooxygenase Inhibitors; Death, Sudden; Dipyridamole; Dogs; Epoprostenol; Hemodynamics; Humans; Myocardial Infarction; Random Allocation; Sulfinpyrazone | 1985 |
Effect of drugs on urate binding to plasma proteins.
Topics: Adult; Allopurinol; Arthritis; Aspirin; Blood Proteins; Chromatography, DEAE-Cellulose; Colchicine; Female; Gout; Humans; Indomethacin; Male; Phenylbutazone; Probenecid; Protein Binding; Sulfinpyrazone; Uric Acid | 1969 |
Sulphinpyrazone, aspirin, and uric acid.
Topics: Aspirin; Death, Sudden; Humans; Myocardial Infarction; Sulfinpyrazone; Uric Acid | 1980 |
Cardiac death prevention in post-myocardial infarction patients: a review.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Animals; Anti-Arrhythmia Agents; Anticoagulants; Arrhythmias, Cardiac; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Disease; Coronary Vessels; Death, Sudden; Disease Models, Animal; Dogs; Estrogens; Female; Follow-Up Studies; Humans; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Recurrence; Sulfinpyrazone; Ventricular Fibrillation | 1980 |
A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
Topics: Adrenergic beta-Antagonists; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Death, Sudden; Dipyridamole; Female; Heart Valve Prosthesis; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Risk; Sulfinpyrazone; Thrombophlebitis | 1980 |
Prophylaxis of myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aspirin; Clinical Trials as Topic; Dipyridamole; Humans; Myocardial Infarction; Sulfinpyrazone; Timolol | 1981 |
Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: a difficult link.
Topics: Acetylation; Aspirin; Blood Platelets; Blood Vessels; Clinical Trials as Topic; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone; Thrombosis; Thromboxane-A Synthase | 1982 |
[Aftercare of heart infarct patients to reduce the risk of a subsequent infarction].
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Clinical Trials as Topic; Dipyridamole; Humans; Hypolipidemic Agents; Myocardial Infarction; Patient Care Planning; Platelet Aggregation; Recurrence; Risk; Sulfinpyrazone; Thiophenes; Ticlopidine | 1983 |
Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Dipyridamole; Double-Blind Method; Humans; Myocardial Infarction; Postoperative Complications; Sulfinpyrazone; Thromboembolism | 1982 |
Platelet tests and antiplatelet drugs in coronary artery disease.
Topics: Adult; Aspirin; beta-Thromboglobulin; Blood Platelets; Cell Survival; Coronary Disease; Dipyridamole; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Platelet Function Tests; Random Allocation; Sulfinpyrazone | 1983 |
[Critical approach to a therapeutic trial in secondary prevention of cerebral ischemic accidents by antiaggregants].
Topics: Adult; Aged; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Dihydroergotoxine; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation; Sulfinpyrazone | 1983 |
[Role of antiplatelet agents in the prevention of cerebral ischemic accidents].
Topics: Adult; Aged; Anticoagulants; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials as Topic; Clofibrate; Dipyridamole; Female; Fibrinolytic Agents; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation; Sulfinpyrazone | 1983 |
Platelets and prostaglandins in coronary artery disease. Rationale for use of platelet-suppressive drugs.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Dogs; Humans; Models, Biological; Platelet Aggregation; Prostaglandins; Sulfinpyrazone | 1983 |
Pharmacological trials: primary and secondary prevention of coronary heart disease.
Topics: Aspirin; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dipyridamole; Estrogens; Humans; Hypercholesterolemia; Male; Middle Aged; Niacin; Sulfinpyrazone | 1983 |
[Place of antiplatelet agents in the prevention of cerebral ischemic strokes].
Topics: Anticoagulants; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone; Time Factors | 1983 |
Role of platelet-active drugs in coronary artery disease.
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Drug Therapy, Combination; Europe; Female; Humans; Male; Myocardial Infarction; Prospective Studies; Research Design; Sulfinpyrazone; Time Factors; United States | 1983 |
Aspirin-sulfinpyrazone in prophylaxis of deep venous thrombosis in total hip replacement.
Topics: Adult; Aged; Aspirin; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Hip Prosthesis; Humans; Male; Middle Aged; Postoperative Complications; Random Allocation; Sex Factors; Sulfinpyrazone; Thrombophlebitis | 1983 |
Prevention of stroke.
Topics: Aged; Aspirin; Canada; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Female; Heparin; Humans; Intracranial Embolism and Thrombosis; Male; Middle Aged; Placebos; Platelet Aggregation; Random Allocation; Risk; Sex Factors; Sulfinpyrazone; United States; Warfarin | 1984 |
Efficacy of antiplatelet drugs in the maintenance of aortocoronary vein bypass graft patency.
Topics: Animals; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Cyclooxygenase Inhibitors; Dipyridamole; Humans; Saphenous Vein; Sulfinpyrazone | 1983 |
Plasma factor and platelet sensitivity to prostacyclin in patients with peripheral vascular disease before and after treatment with a combination of a cyclooxygenase and a phosphodiesterase inhibitor.
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Dipyridamole; Drug Therapy, Combination; Epoprostenol; Humans; Male; Phosphodiesterase Inhibitors; Sulfinpyrazone; Vascular Diseases | 1984 |
Medical Grand Rounds: extracranial carotid artery disease.
Topics: Adolescent; Adult; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Auscultation; Carotid Artery Diseases; Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Sulfinpyrazone | 1980 |
[Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review].
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation; Recurrence; Sulfinpyrazone | 1982 |
Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
Topics: Animals; Anticoagulants; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Female; Humans; In Vitro Techniques; Male; Placebos; Platelet Adhesiveness; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1980 |
The Canadian trial of aspirin and sulfinpyrazone in threatened stroke.
Topics: Aged; Anticoagulants; Aspirin; Blood Platelets; Canada; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Endarterectomy; Humans; Ischemic Attack, Transient; Male; Sulfinpyrazone | 1980 |
Randomized trial of therapy with platelet antiaggregants for threatened stroke.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Placebos; Platelet Aggregation; Sulfinpyrazone | 1980 |
The anturane reinfarction trial.
Topics: Adult; Aspirin; Clinical Trials as Topic; Female; Gastric Mucosa; Humans; Male; Sulfinpyrazone | 1980 |
Aspirin and recurrent myocardial infarction.
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Female; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Recurrence; Sex Factors; Sulfinpyrazone | 1980 |
Secondary prevention of myocardial infarction--the present state of the ART.
Topics: Anticoagulants; Aspirin; Blood Platelets; Clinical Trials as Topic; Dipyridamole; Humans; Myocardial Infarction; Recurrence; Sulfinpyrazone; Thrombosis | 1980 |
Sulfinpyrazone: a review of its pharmacological properties and therapeutic use.
Topics: Animals; Anti-Arrhythmia Agents; Antibody Formation; Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clinical Trials as Topic; Fibrinolytic Agents; Humans; Platelet Aggregation; Prostaglandins; Sulfinpyrazone; Thrombosis | 1980 |
Summary of design features: clinical trials of platelet-active drugs in cerebrovascular disease.
Topics: Aspirin; Blood Platelets; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Ischemic Attack, Transient; Male; Patient Compliance; Placebos; Sulfinpyrazone | 1980 |
A randomized trial of aspirin and sulfinpyrazone in patients with threatened stroke. Results and methodologic issues.
Topics: Actuarial Analysis; Aspirin; Canada; Cerebrovascular Disorders; Clinical Trials as Topic; Death, Sudden; Female; Follow-Up Studies; Humans; Ischemic Attack, Transient; Male; Patient Compliance; Random Allocation; Risk; Sulfinpyrazone | 1980 |
Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon.
Topics: 4-Hydroxycoumarins; Aged; Aspirin; Clinical Trials as Topic; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Phenprocoumon; Random Allocation; Sex Factors; Sulfinpyrazone | 1980 |
Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
Topics: Adult; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Dipyridamole; Female; Humans; Male; Middle Aged; Myocardial Infarction; Sex Factors; Sulfinpyrazone | 1981 |
Series on pharmacology in practice. 10. Antithrombotic therapy: role of platelet-inhibitor drugs. III. Management of arterial thromboembolic and atherosclerotic disease (third of three parts).
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Sulfinpyrazone; Thromboembolism; Thrombosis | 1981 |
[The platelet inhibitor problem].
Topics: Aspirin; Blood Transfusion; Brain Ischemia; Clinical Trials as Topic; Female; Humans; Male; Myocardial Infarction; Platelet Aggregation; Recurrence; Sulfinpyrazone | 1981 |
[Platelet antiaggregants: review of the literature (author's transl)].
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation; Sulfinpyrazone; Thromboembolism | 1981 |
[Platelets and coronary artery disease (CAD) (author's transl)].
Topics: Animals; Aspirin; Autopsy; Blood Platelets; Cardiomyopathies; Cell Wall; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Heparin Antagonists; Humans; Platelet Aggregation; Risk; Sulfinpyrazone | 1980 |
Drug trials in prevention of occlusion of aorta--coronary artery vein grafts.
Topics: Angiography; Aspirin; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Humans; Postoperative Care; Random Allocation; Risk; Sulfinpyrazone; Thrombosis; Veins; Warfarin | 1982 |
Anti platelet agents for strokes and myocardial infarction: a critical appraisal of recent clinical trials.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Collagen; Coronary Disease; Dipyridamole; Evaluation Studies as Topic; Humans; Myocardial Infarction; Platelet Aggregation; Prostaglandins; Recurrence; Sulfinpyrazone; Thromboxanes | 1981 |
E.P.S.I.M., the French oral anticoagulant--aspirin trial in post-myocardial infarction patients: design, organization and quality control procedures.
Topics: Administration, Oral; Adult; Aged; Anticoagulants; Aspirin; Clinical Trials as Topic; Data Collection; Dipyridamole; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Prognosis; Random Allocation; Recurrence; Sulfinpyrazone | 1981 |
Antiplatelet agents: their role in the prevention of sudden death.
Topics: Animals; Aspirin; Blood Platelets; Cell Survival; Clinical Trials as Topic; Coronary Circulation; Coronary Disease; Death, Sudden; Dipyridamole; Dogs; Endothelium; Humans; Male; Muscle, Smooth; Myocardial Infarction; Papio; Platelet Adhesiveness; Prostaglandins; Rabbits; Sulfinpyrazone | 1982 |
[Thrombosis prevention with thrombocyte aggregation inhibitors in the venous system].
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone; Thrombophlebitis | 1982 |
Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cell Division; Clinical Trials as Topic; Coronary Disease; Dipyridamole; Heart Diseases; Humans; Hydroxychloroquine; Neoplasms; Sulfinpyrazone; Thromboembolism; Thrombosis | 1982 |
Antiplatelet therapy and cerebrovascular diseases.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Double-Blind Method; Humans; Sulfinpyrazone | 1982 |
The anturane reinfarction trial.
Topics: Aspirin; Blood Platelets; Death, Sudden; Female; Humans; Male; Myocardial Infarction; Placebos; Sulfinpyrazone; Thromboembolism; Time Factors | 1980 |
Use of cumulative meta-analysis in the design, monitoring, and final analysis of a clinical trial: a case study.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clinical Protocols; Clinical Trials as Topic; Coronary Artery Bypass; Dipyridamole; Humans; Meta-Analysis as Topic; Placebos; Platelet Aggregation Inhibitors; Saphenous Vein; Sulfinpyrazone; Uricosuric Agents | 1995 |
224 other study(ies) available for aspirin and sulfinpyrazone
| Article | Year |
|---|---|
Inhibitors of blood platelet aggregation. Effects of some 1,2-benzisothiazol-3-ones on platelet responsiveness to adenosine diphosphate and collagen.
Topics: Adenosine Diphosphate; Animals; Chemical Phenomena; Chemistry; Collagen; Guinea Pigs; Humans; Male; Platelet Aggregation; Rats; Structure-Activity Relationship; Thiazoles | 1985 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Antiplatelet drugs in a rat microsurgical model of arterial thrombosis.
Topics: Animals; Aspirin; Blood Coagulation; Blood Platelets; Carotid Artery Thrombosis; Dipyridamole; Disease Models, Animal; Hydrogen-Ion Concentration; Male; Polyethylene Glycols; Rats; Sodium Chloride; Sulfinpyrazone | 1979 |
Factors responsible for ADP-induced release reaction of human platelets.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Aspirin; Citrates; Fibrinogen; gamma-Globulins; Hemophilia A; Heparin; Hirudins; Humans; Magnesium; Phenylbutazone; Phosphates; Platelet Adhesiveness; Platelet Aggregation; Serum Albumin; Sulfinpyrazone; Thrombin | 1975 |
Aspirin and stroke prevention.
Topics: Adult; Aspirin; Cerebrovascular Disorders; Female; Humans; Ischemic Attack, Transient; Male; Risk; Sex Factors; Sulfinpyrazone | 1978 |
Experimental arterial thromboembolism in baboons. Mechanism, quantitation, and pharmacologic prevention.
Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Blood Transfusion; Dipyridamole; Disease Models, Animal; Femoral Artery; Femoral Vein; Fibrinogen; Haplorhini; Heparin; Kidney; Male; Papio; Platelet Adhesiveness; Polyurethanes; Regional Blood Flow; Silicone Elastomers; Sulfinpyrazone; Thromboembolism | 1979 |
Interference by sulfinpyrazone and salicylate of aspirin inhibition of platelet cyclooxygenase activity.
Topics: Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; Humans; Prostaglandin-Endoperoxide Synthases; Salicylates; Sulfinpyrazone | 1979 |
Effects of inhibitors of platelets aggregation on oxidative phosphorylation in rat liver mitochondria in vitro.
Topics: Adenosine Triphosphatases; Animals; Aspirin; Dipyridamole; In Vitro Techniques; Male; Mitochondria, Liver; Nicergoline; Oxidative Phosphorylation; Oxygen Consumption; Platelet Aggregation; Rats; Sulfinpyrazone | 1979 |
In vitro evaluation of inhibitors of platelet release and aggregation.
Topics: Adenosine; Adenosine Diphosphate; Anti-Inflammatory Agents; Antilymphocyte Serum; Aspirin; Blood Platelets; Collagen; Depression, Chemical; Dextrans; Dipyridamole; Epinephrine; Hematology; Humans; Molecular Weight; Phosphoric Monoester Hydrolases; Platelet Adhesiveness; Platelet Aggregation; Propionates; Prostaglandins E; Serotonin; Sulfinpyrazone; T-Lymphocytes | 1975 |
Platelet release and aggregation induced by antithymocyte globulin. In vitro effect of inhibitors.
Topics: Adenosine; Antilymphocyte Serum; Apyrase; Aspirin; Blood Platelets; Dipyridamole; Flurbiprofen; Humans; Phosphoric Monoester Hydrolases; Platelet Aggregation; Propionates; Prostaglandins E; Sulfinpyrazone; T-Lymphocytes | 1975 |
Evaluation of antiinflammatory and antithrombotic drugs in pulmonary and arterial thrombosis.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Animals; Anti-Inflammatory Agents; Arterial Occlusive Diseases; Aspirin; Benzophenones; Carotid Arteries; Cattle; Dipyridamole; Drug Evaluation; Fibrinolytic Agents; Humans; Imidazoles; Indoles; Indomethacin; Lung Diseases, Obstructive; Male; Mice; Platelet Aggregation; Prostaglandins; Pyridines; Quinazolines; Rats; Sulfinpyrazone; Sulfonamides; Suloctidil; Thiophenes | 1979 |
[Evaluation of antithrombin III activity in ischemic cardiopathy: changes due to treatment with platelet anti-aggregants].
Topics: Anticoagulants; Antithrombin III; Aspirin; Coronary Disease; Female; Humans; Male; Platelet Aggregation; Sulfinpyrazone | 1979 |
Treating thromboembolic disease.
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Fibrinolytic Agents; Heart Valve Prosthesis; Heparin; Humans; Ischemic Attack, Transient; Platelet Aggregation; Sulfinpyrazone; Thromboembolism | 1977 |
Effects of sulphinpyrazone and aspirin on gastrointestinal blood loss in man.
Topics: Aspirin; Gastrointestinal Hemorrhage; Humans; Placebos; Sulfinpyrazone | 1978 |
Effects of sulphinpyrazone and aspirin on prostaglandin I2 (prostacyclin) synthesis by endothelial cells.
Topics: Aspirin; Cells, Cultured; Endothelium; Epoprostenol; Prostaglandins; Sulfinpyrazone | 1978 |
An in vitro method for platelet morphological studies employing a reconstituted collagen substrate.
Topics: Animals; Aspirin; Blood Platelets; Cell Adhesion; Collagen; Culture Media; Epoprostenol; Male; Microscopy, Electron, Scanning; Platelet Aggregation; Rabbits; Sulfinpyrazone | 1979 |
[Therapy with anticoagulants and platelet aggregation inhibitors in extracranial vascular stenoses and occlusions].
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cerebral Infarction; Cerebrovascular Disorders; Dipyridamole; Heparin; Humans; Ischemic Attack, Transient; Platelet Aggregation; Sulfinpyrazone; Thromboembolism | 1979 |
Transient ischemic attacks due to increased platelet aggregation and adhesiveness. Ultrastructural and functional correlation.
Topics: Adolescent; Adult; Aspirin; Blood Coagulation Tests; Blood Platelet Disorders; Blood Platelets; Dipyridamole; Female; Hemostasis; Humans; Ischemic Attack, Transient; Male; Microscopy, Electron, Scanning; Middle Aged; Platelet Adhesiveness; Platelet Aggregation; Sulfinpyrazone | 1979 |
[Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
Topics: Anticoagulants; Aspirin; Coronary Disease; Dipyridamole; Humans; Ischemic Attack, Transient; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Sulfinpyrazone; Thrombophlebitis; Thrombosis | 1979 |
Status of antiplatelet drugs in coronary heart disease.
Topics: Aspirin; Blood Platelets; Clofibrate; Coronary Disease; Dipyridamole; Humans; Male; Models, Biological; Platelet Aggregation; Propranolol; Sulfinpyrazone | 1979 |
[Effects of heparin, sulfinpyrazone and acetylsalicylic acid on the collagen-induced thromboyte aggregation].
Topics: Aspirin; Heparin; Humans; In Vitro Techniques; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1979 |
[Current status of vascular diseases and their treatment].
Topics: Arteriosclerosis; Aspirin; Clofibrate; Humans; Indomethacin; Sulfinpyrazone; Vasodilator Agents | 1979 |
The influence of red blood cells on the effects of aspirin or sulphinpyrazone on platelet adherence to damaged rabbit aorta.
Topics: Animals; Aorta, Thoracic; Aspirin; Depression, Chemical; Endothelium; Erythrocytes; Hematocrit; In Vitro Techniques; Microscopy, Electron, Scanning; Platelet Adhesiveness; Rabbits; Sulfinpyrazone | 1979 |
[Medical therapy of thrombosis].
Topics: Anticoagulants; Antihypertensive Agents; Aspirin; Fibrinolytic Agents; Humans; Hypolipidemic Agents; Phenylbutazone; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1979 |
The Canadian cooperative study of platelet suppressant therapy in threatened stroke.
Topics: Aspirin; Blood Platelets; Canada; Cerebrovascular Disorders; Double-Blind Method; Evaluation Studies as Topic; Female; Humans; Male; Patient Compliance; Prognosis; Sulfinpyrazone | 1979 |
Is the antithrombotic activity of "antiplatelet" drugs based on protection of endothelium?
Topics: Animals; Aspirin; Citrates; Clofibrate; Dipyridamole; Endothelium; Female; Hydroxychloroquine; Platelet Aggregation; Rats; Sulfinpyrazone | 1979 |
[Inhibitors of platelet aggregation in the therapy of arteriosclerosis obliterans].
Topics: Arteriosclerosis Obliterans; Aspirin; Diabetic Angiopathies; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1979 |
The effect of agents which modify platelet behaviour and of magnesium ions on thrombus formation in vivo.
Topics: Animals; Aspirin; Blood Coagulation; Blood Platelets; Dipyridamole; Fibrinolytic Agents; Flurbiprofen; Heparin; Magnesium Sulfate; Morpholines; Pyrimidines; Rabbits; Sulfinpyrazone | 1979 |
Effects of acetylsalicylic acid, sulfinpyrazone and dipyridamole on platelet adhesion and aggregation in flowing native and anticoagulated blood.
Topics: Animals; Aspirin; Blood Platelets; Blood Vessels; Citrates; Dipyridamole; Dose-Response Relationship, Drug; Endothelium; Female; Male; Platelet Adhesiveness; Platelet Aggregation; Rabbits; Sulfinpyrazone; Thrombosis | 1979 |
[New specialties, registered in Austria. Anturane 200 mg dragees, regulator of platelet function].
Topics: Aspirin; Austria; Drug Interactions; Drug Tolerance; Pharmacopoeias as Topic; Platelet Aggregation; Sulfinpyrazone; Thromboembolism; Uric Acid | 1979 |
[Antiplatelet drugs (author's transl)].
Topics: Aspirin; Blood Platelets; Clofibrate; Dipyridamole; Female; Humans; Hydroxychloroquine; Ischemic Attack, Transient; Male; Myocardial Infarction; Nicergoline; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1979 |
Trials of antiplatelet drugs: some methodological considerations.
Topics: Aspirin; Brain Ischemia; Cerebrovascular Disorders; Coronary Disease; Drug Therapy, Combination; Female; Humans; Male; Myocardial Infarction; Placebos; Platelet Aggregation; Random Allocation; Research Design; Sulfinpyrazone | 1979 |
Antiplatelet treatment of thrombotic thrombocytopenic purpura.
Topics: Adolescent; Adult; Aged; Aspirin; Blood Platelets; Cyproheptadine; Dextrans; Dipyridamole; Female; Humans; Male; Middle Aged; Purpura, Thrombotic Thrombocytopenic; Splenectomy; Sulfinpyrazone | 1977 |
Platelet-latelet-.
Topics: Adult; Aspirin; Blood Platelets; Depression, Chemical; Dipyridamole; Female; Humans; Methylprednisolone; Middle Aged; Prednisone; Purpura, Thrombotic Thrombocytopenic; Remission, Spontaneous; Sulfinpyrazone | 1977 |
Antiplatelet agents in the treatment of thrombotic complications of primary thrombocythemia.
Topics: Aged; Aspirin; Humans; Male; Sulfinpyrazone; Thrombocythemia, Essential; Thrombosis | 1979 |
Reversible and irreversible inhibition of platelet cyclooxygenase and serotonin release by nonsteroidal antinflammatory drugs.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Blood Platelets; Cattle; Collagen; Fenoprofen; Humans; Naproxen; Oxygenases; Phenylbutazone; Serotonin; Serotonin Antagonists; Sulfinpyrazone | 1978 |
Thrombotic thrombocytopenic purpura: failure of plasma infusion and antiplatelet agents.
Topics: Adult; Aspirin; Blood Platelets; Dipyridamole; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Humans; Plasmapheresis; Prednisone; Purpura, Thrombotic Thrombocytopenic; Sulfinpyrazone | 1979 |
Thrombotic and hemorrhagic problems in surgery.
Topics: Aspirin; Blood Coagulation Factors; Dextrans; Extracorporeal Circulation; Female; Hemostasis; Heparin; Humans; Male; Respiratory Insufficiency; Sulfinpyrazone; Surface Properties; Surgical Procedures, Operative; Thrombosis | 1978 |
Platelet suppressing drugs in arterial disease.
Topics: Anticoagulants; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Humans; Myocardial Infarction; Sulfinpyrazone; Vascular Diseases | 1978 |
The retired breeder rat as a new model for antiplatelet drug discovery.
Topics: Animals; Aspirin; Breeding; Dipyridamole; Male; Platelet Aggregation; Prostaglandins E; Rats; Sulfinpyrazone | 1977 |
Assessment of antithrombotic drugs ex vivo and in vivo.
Topics: Animals; Aspirin; Citrates; Collagen; Dipyridamole; Fibrinolytic Agents; Heparin; Platelet Aggregation; Rabbits; Sulfinpyrazone | 1977 |
[Treatment of transient ischemic attacks (author's transl)].
Topics: Angiography; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Endarterectomy; Humans; Ischemic Attack, Transient; Platelet Aggregation; Sulfinpyrazone | 1978 |
[Platelet-inhibiting drugs].
Topics: Anti-Bacterial Agents; Aspirin; Dextrans; Dipyridamole; Hemorrhage; Humans; Indomethacin; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1978 |
Antiplatelet therapy (first of two parts).
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Blood Coagulation; Blood Platelets; Cell Survival; Clofibrate; Dextrans; Dipyridamole; Heparin; Humans; Platelet Adhesiveness; Platelet Aggregation; Propranolol; Rabbits; Sulfinpyrazone; Thrombosis | 1978 |
Antiplatelet agents in coronary disease: are they of prophylactic value?
Topics: Angina Pectoris; Aspirin; Cardiopulmonary Bypass; Clofibrate; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Heart Valve Prosthesis; Humans; Myocardial Infarction; Recurrence; Sulfinpyrazone | 1978 |
Comparison of antithrombotic activity of heparin, ASA, sulfinpyrazone and VK 744 in a rat model of arterial thrombosis.
Topics: Animals; Aspirin; Blood Coagulation; Carotid Arteries; Carotid Artery Thrombosis; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fibrinolytic Agents; Heparin; Male; Pyrimidines; Rats; Sulfinpyrazone | 1978 |
Stroke prevention.
Topics: Aspirin; Cerebrovascular Disorders; Drug Therapy, Combination; Humans; Sex Factors; Sulfinpyrazone | 1978 |
Vasomotor phenomena, platelet antagonism and migraine therapy.
Topics: Aspirin; Ergotamine; Fenoprofen; Humans; Migraine Disorders; Platelet Aggregation; Serotonin; Sulfinpyrazone | 1978 |
[Platelet inhibitory agents in the prevention of infarct].
Topics: Aspirin; Blood Platelets; Humans; Myocardial Infarction; Sulfinpyrazone | 1978 |
Effect of acetylsalicylic acid, sulfinpyrazone and their combination on collagen-induced platelet aggregation in guinea pigs.
Topics: Animals; Aspirin; Blood Proteins; Collagen; Drug Interactions; Guinea Pigs; Platelet Aggregation; Protein Binding; Sulfinpyrazone | 1978 |
[Influence of Anturane on platelets aggregation. Comparative study with acetylsalicylic acid in patients with and without oral anticoagulant therapy].
Topics: Administration, Oral; Anticoagulants; Aspirin; Coumarins; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Humans; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1978 |
[Results of clinical studies on the effect of aggregation inhibitors in arterial diseases].
Topics: Arterial Occlusive Diseases; Aspirin; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1979 |
Antithrombotic therapy. Rationale and application.
Topics: Anticoagulants; Arteries; Arteriosclerosis; Aspirin; Blood Coagulation; Blood Coagulation Factors; Dipyridamole; Fibrinolytic Agents; Humans; Platelet Adhesiveness; Sulfinpyrazone; Thrombophlebitis; Thrombosis; Urokinase-Type Plasminogen Activator; Veins; Warfarin | 1979 |
[Effect of heparin, acetylsalicylic acid and sulfinpyrazone on thrombocyte morphology].
Topics: Aspirin; Blood Platelets; Heparin; Humans; Sulfinpyrazone; Thrombosis | 1979 |
[Prophylaxis and therapy of shunt thrombosis in terminal renal insufficiency (author's transl)].
Topics: Anticoagulants; Arteriovenous Shunt, Surgical; Aspirin; Dextrans; Dipyridamole; Hemorrhagic Disorders; Heparin; Humans; Renal Dialysis; Sulfinpyrazone; Thrombosis; Uremia | 1977 |
The pharmacology of the hypouricemic effect of benzbromarone.
Topics: Aspirin; Benzbromarone; Benzofurans; Blood Proteins; Drug Interactions; Glomerular Filtration Rate; Kidney Tubules; Protein Binding; Pyrazinamide; Sulfinpyrazone; Uric Acid; Xanthine Oxidase | 1977 |
Classification of uricosuric states based upon response to pharmacologic inhibitors of urate transport.
Topics: Anemia, Sickle Cell; Aspirin; Biological Transport; Diatrizoate; Fanconi Syndrome; Glomerular Filtration Rate; Humans; Kidney Tubules; Probenecid; RNA; Saline Solution, Hypertonic; Sulfinpyrazone; Uric Acid; Water-Electrolyte Balance | 1977 |
Inhibition of platelet adhesion to rabbit aorta by sulphinpyrazone and acetylsalicylic acid.
Topics: Animals; Aorta; Aspirin; Collagen; Microscopy, Electron, Scanning; Perfusion; Platelet Adhesiveness; Platelet Aggregation; Rabbits; Sulfinpyrazone | 1977 |
Anticoagulants and platelet-inhibiting drugs in stroke.
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1977 |
Effects of aspirin and sulfinpyrazone on platelet prostaglandin synthesis.
Topics: Aspirin; Blood Platelets; Collagen; Ischemic Attack, Transient; Kinetics; Prostaglandins; Serotonin; Sulfinpyrazone | 1977 |
Inhibition of platelet adherence to damaged vessel wall by drugs.
Topics: Animals; Aorta; Aspirin; Cephalothin; Depression, Chemical; In Vitro Techniques; Penicillin G; Platelet Adhesiveness; Rabbits; Reserpine; Sulfinpyrazone | 1977 |
Effect of drugs of platelets and complications of vascular disease.
Topics: Animals; Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Clofibrate; Coronary Disease; Death, Sudden; Dipyridamole; Humans; Ischemic Attack, Transient; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1977 |
Using antithrombotic therapy in ischemic cerebrovascular disease.
Topics: Aspirin; Brain; Cerebrovascular Disorders; Dipyridamole; Fibrinolytic Agents; Heparin; Humans; Intracranial Embolism and Thrombosis; Ischemia; Sulfinpyrazone; Warfarin | 1977 |
Platelets, thrombosis and atherosclerosis.
Topics: Arteries; Arteriosclerosis; Aspirin; Blood Platelets; Cell Division; Cell Survival; Dipyridamole; Endothelium; Humans; Platelet Adhesiveness; Sulfinpyrazone; Thrombosis | 1977 |
[Pharmacology of aggregation inhibitors].
Topics: Aspirin; Dextrans; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1976 |
Use of platelet antagonists in the treatment of migraine.
Topics: Aspirin; Blood Platelets; Dipyridamole; Migraine Disorders; Platelet Aggregation; Sulfinpyrazone | 1976 |
Registry of prospective clinical trials second report.
Topics: Adult; Aged; Aspirin; Blood Platelets; Dipyridamole; Drug Evaluation; Female; Fibrinolytic Agents; Hemostatics; Humans; International Agencies; Male; Middle Aged; Plasminogen; Registries; Streptokinase; Sulfinpyrazone; Urokinase-Type Plasminogen Activator; Venoms | 1976 |
Are agents affecting platelet function clinically useful in patients with coronary artery disease?
Topics: Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Clofibrate; Coronary Disease; Dipyridamole; Humans; Myocardial Infarction; Sulfinpyrazone | 1976 |
Platelet survival time following aortic valve replacement.
Topics: Adult; Aortic Valve; Aortic Valve Insufficiency; Aortic Valve Stenosis; Aspirin; Blood Platelets; Cell Survival; Chromium Radioisotopes; Dipyridamole; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Sulfinpyrazone; Thromboembolism; Time Factors; Transplantation, Autologous; Warfarin | 1975 |
Increased platelet aggregability in young patients with stroke. Diagnosis and therapy.
Topics: Adult; Aspirin; Blood Coagulation Tests; Blood Platelet Disorders; Cell Survival; Cerebrovascular Disorders; Contraceptives, Oral; Drug Therapy, Combination; Female; Humans; Male; Platelet Adhesiveness; Platelet Aggregation; Pregnancy; Pyridinolcarbamate; Recurrence; Sulfinpyrazone; Warfarin | 1975 |
Letter: Medical management of transient ischaemic attacks.
Topics: Anti-Inflammatory Agents; Anticoagulants; Aspirin; Dipyridamole; Humans; Ischemic Attack, Transient; Sulfinpyrazone | 1975 |
Platelet adhesiveness.
Topics: Anti-Inflammatory Agents; Aspirin; Blood Platelets; Collagen; Dextrans; Endothelium; Fibrinogen; Heparin; Humans; Phenylbutazone; Platelet Adhesiveness; Sialic Acids; Sulfinpyrazone; Thromboembolism | 1975 |
Proceedings: Comparison of in vivo and in vitro effects of platelet function suppressing drugs.
Topics: Animals; Aspirin; Blood Platelets; Cell Survival; Dipyridamole; In Vitro Techniques; Platelet Aggregation; Rabbits; Sulfinpyrazone; Thromboembolism | 1975 |
Proceedings: The effect of sulphinpyrazone, sodium aspirin and oxprenolol on the formation of arterial platelet thrombi.
Topics: Animals; Aspirin; Blood Coagulation; Blood Platelets; Cricetinae; Fibrinolytic Agents; Male; Oxprenolol; Sulfinpyrazone | 1975 |
The pharmacology of hypouricemic effect of benzbromarone.
Topics: Adult; Aspirin; Benzbromarone; Benzofurans; Blood Proteins; Creatinine; Female; Gout; Humans; Male; Middle Aged; Protein Binding; Pyrazinamide; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1975 |
Pharmacological properties of drug inhibiting platelet aggregation.
Topics: Aspirin; Dipyridamole; Humans; In Vitro Techniques; Platelet Aggregation; Sulfinpyrazone; Thrombosis | 1975 |
Clinical pharmacology of anti-aggregating substances.
Topics: Aspirin; Clofibrate; Dextrans; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1975 |
[Strategies for antiplatelet therapy-drug-fixed method and suppression-fixed method].
Topics: Aspirin; Cerebral Infarction; Dipyridamole; Drug Therapy, Combination; Humans; Myocardial Infarction; Platelet Aggregation; Recurrence; Sulfinpyrazone; Ticlopidine | 1992 |
[Antiplatelet therapy in cardiac diseases].
Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Artery Bypass; Humans; Mitral Valve Prolapse; Myocardial Infarction; Platelet Aggregation Inhibitors; Sulfinpyrazone; Ticlopidine | 1992 |
[Inhibitor of thromboxane A2 synthesis as anticoagulant in hemodialysis].
Topics: Animals; Aspirin; Blood Coagulation Disorders; Cyclooxygenase Inhibitors; Dogs; Fatty Acids, Monounsaturated; Humans; Methacrylates; Phospholipases; Receptors, Prostaglandin; Receptors, Thromboxane; Renal Dialysis; Sulfinpyrazone; Thromboxane A2; Thromboxane-A Synthase | 1991 |
Human equivalent doses of platelet inhibitors and experimental atherosclerosis.
Topics: Animals; Aorta; Arteriosclerosis; Aspirin; Blood Platelets; Dipyridamole; Dose-Response Relationship, Drug; Rabbits; Sulfinpyrazone | 1990 |
Antiplatelet therapy to prevent coronary artery bypass graft occlusion.
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Drug Combinations; Graft Occlusion, Vascular; Humans; Platelet Aggregation Inhibitors; Sulfinpyrazone | 1990 |
Influence of cardioprotective cyclooxygenase and lipoxygenase inhibitors on peroxidative injury to myocardial-membrane phospholipid.
Topics: Aspirin; Cyclooxygenase Inhibitors; Fatty Acids, Unsaturated; Humans; Indomethacin; Lipid Peroxidation; Lipid Peroxides; Lipoxygenase Inhibitors; Membrane Lipids; Myocardial Reperfusion Injury; Naproxen; Sulfinpyrazone; Superoxides; Time Factors; Xanthine Oxidase | 1989 |
Clinical trials on the efficacy of pharmacologic intervention reducing mortality from cardiovascular diseases.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Clofibrate; Coronary Disease; Dextrothyroxine; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Estrogens; Humans; Hypertension; Myocardial Infarction; Niacin; Sulfinpyrazone | 1985 |
[Antiaggregants of thrombocytes in ischemic heart disease].
Topics: Adrenergic beta-Antagonists; Aspirin; Coronary Disease; Dipyridamole; Fibrinolytic Agents; Humans; Molsidomine; Nitroprusside; Platelet Aggregation; Sulfinpyrazone; Sydnones; Verapamil | 1985 |
A sensitive model of venous thrombosis in rats.
Topics: Animals; Anticoagulants; Aspirin; Dipyridamole; Disease Models, Animal; Female; Heparin; Ketanserin; Piperidines; Rats; Rats, Inbred Strains; Sulfinpyrazone; Thrombophlebitis; Time Factors | 1986 |
Antithrombotics in view of thrombosis models.
Topics: Animals; Anticoagulants; Arteries; Aspirin; Dipyridamole; Female; Hydroxyethylrutoside; Ketanserin; Piperidines; Pizotyline; Prenylamine; Rats; Rats, Inbred Strains; Sulfinpyrazone; Thrombophlebitis; Thrombosis | 1986 |
[Secondary prevention of peripheral arterial occlusive diseases].
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Coumarins; Dipyridamole; Humans; Sulfinpyrazone | 1987 |
Prolongation of platelet survival in hypercholesterolaemic rabbits by CGS 12970 (3-methyl-2-(3-pyridyl)-1 indoleoctanoic acid) and dazoxiben.
Topics: Animals; Aspirin; Blood Platelets; Cell Survival; Cholesterol, Dietary; Cyclooxygenase Inhibitors; Hypercholesterolemia; Imidazoles; Pyridines; Rabbits; Sulfinpyrazone; Thromboxane B2; Thromboxane-A Synthase | 1987 |
Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Combinations; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Prognosis; Random Allocation; Sulfinpyrazone | 1988 |
Platelet-inhibitor therapy in cardiovascular disease. Effective defense against thromboembolism.
Topics: Angioplasty, Balloon; Anticoagulants; Aspirin; Bioprosthesis; Blood Platelets; Coronary Disease; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Graft Occlusion, Vascular; Heart Valve Prosthesis; Heparin; Humans; Prothrombin Time; Random Allocation; Sulfinpyrazone; Thromboembolism; Time Factors; Warfarin | 1985 |
[Anti-aggregation therapy of patients with ischemic heart disease].
Topics: Aspirin; Coronary Disease; Dipyridamole; Drug Evaluation; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Sulfinpyrazone; Ticlopidine | 1988 |
Effective antiplatelet drug concentrations in experimental arterial thromboembolism.
Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Dipyridamole; Kinetics; Male; Papio; Sulfinpyrazone; Thromboembolism | 1987 |
[Role of platelet anti-aggregants in cardiovascular surgery].
Topics: Aspirin; Coronary Artery Bypass; Dipyridamole; Graft Occlusion, Vascular; Humans; Platelet Aggregation; Sulfinpyrazone; Ticlopidine | 1987 |
[Mode of action and clinical evaluation of platelet aggregation inhibitors].
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Graft Occlusion, Vascular; Humans; Ketanserin; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone; Ticlopidine | 1987 |
The consent form as a possible cause of side effects.
Topics: Angina Pectoris; Aspirin; Clinical Trials as Topic; Digestive System; Humans; Informed Consent; Placebos; Sulfinpyrazone; Surveys and Questionnaires | 1987 |
Platelet aggregation and atherosclerosis.
Topics: Arteriosclerosis; Aspirin; Dipyridamole; Electrocardiography; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone | 1986 |
Etiology and prevention of thromboembolic disease. Taming a complex circulatory malfunction.
Topics: Antithrombin III Deficiency; Aspirin; Blood Coagulation Disorders; Catheters, Indwelling; Contraceptives, Oral; Dihydroergotamine; Female; Glycoproteins; Heparin; Humans; Parity; Postoperative Complications; Pregnancy; Pregnancy Complications; Protein C; Sulfinpyrazone; Thrombophlebitis; Warfarin | 1986 |
[Prevention and medical treatment of polyregional vascular lesions].
Topics: Adult; Anticoagulants; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Diet; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Risk; Sulfinpyrazone; Thiophenes; Thrombosis; Ticlopidine | 1985 |
[Prostaglandin studies in normal subjects and in post-myocardial infarct patients].
Topics: Adult; Aspirin; Child; Dinoprost; Female; Humans; Indomethacin; Male; Myocardial Infarction; Physical Exertion; Prostaglandins F; Renin-Angiotensin System; Sulfinpyrazone | 1985 |
Differential inhibition of platelet thromboxane and lung prostacyclin production by sulphinpyrazone, acetylsalicylic acid and indomethacin by human tissues in vitro.
Topics: 6-Ketoprostaglandin F1 alpha; Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; Epoprostenol; Humans; In Vitro Techniques; Indomethacin; Lung; Sulfinpyrazone; Thromboxane A2; Thromboxane B2 | 1985 |
Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition.
Topics: Animals; Aspirin; Blood Platelets; Cell Survival; Cyclooxygenase Inhibitors; Dipyridamole; Drug Synergism; Femoral Artery; Fibrinolytic Agents; Imidazoles; Male; Papio; Sulfinpyrazone; Thromboembolism | 1985 |
Interaction of non-steroidal anti-inflammatory drugs on platelet cyclo-oxygenase and lipoxygenase activity.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Humans; Indomethacin; Kinetics; Lipoxygenase; Models, Biological; Prostaglandin-Endoperoxide Synthases; Salicylates; Salicylic Acid; Sulfinpyrazone | 1985 |
Antiplatelet aggregators inhibit development of stress ulcers in Sprague-Dawley rats.
Topics: Animals; Anticoagulants; Aspirin; Capillaries; Dipyridamole; Gastric Mucosa; Male; Platelet Aggregation; Pyridines; Rats; Rats, Inbred Strains; Stomach Ulcer; Stress, Physiological; Sulfinpyrazone; Thiophenes; Thrombosis; Ticlopidine | 1985 |
[Site of action of anticoagulant drugs].
Topics: Administration, Oral; Anticoagulants; Aspirin; Dipyridamole; Hemostasis; Heparin; Humans; Sulfinpyrazone | 1985 |
The influence of antiplatelet drugs on injury-stimulated migration of cultured smooth muscle cells.
Topics: Animals; Arteriosclerosis; Aspirin; Catheterization; Cell Movement; Cells, Cultured; Dipyridamole; Hypophysectomy; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred Strains; Sulfinpyrazone | 1985 |
Modification of platelet adherence to protein-coated surfaces.
Topics: Animals; Antimycin A; Aspirin; Caffeine; Carbon Isotopes; Cyclic AMP; Fibrinogen; gamma-Globulins; Glass; Iodine Isotopes; Iodoacetates; Phenylbutazone; Platelet Adhesiveness; Prostaglandins; Pyrimidines; Serotonin; Serum Albumin, Bovine; Sulfinpyrazone; Swine | 1973 |
Platelet-surface reaction and thrombosis.
Topics: Animals; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Carbon Isotopes; Endarterectomy; Extracorporeal Circulation; Femoral Artery; Fibrinogen; gamma-Globulins; Glass; Humans; In Vitro Techniques; Polymers; Popliteal Artery; Pulse; Rabbits; Serotonin; Serum Albumin; Sulfinpyrazone; Sulfur Isotopes; Surface Properties; Thrombosis; Transplantation, Autologous; Vascular Surgical Procedures | 1968 |
Adhesion of human blood platelets to glass and polymer surfaces. I. Studies with platelets in plasma.
Topics: Adult; Age Factors; Amitriptyline; Aspirin; Blood Coagulation Disorders; Chloromercuribenzoates; Chlorpromazine; Citrates; Desipramine; Edetic Acid; Glass; Glucosamine; Heparin; Humans; Imipramine; Middle Aged; Platelet Adhesiveness; Polyethylenes; Polymers; Polytetrafluoroethylene; Polyvinyl Chloride; Promethazine; Sulfinpyrazone | 1974 |
Pharmacologic effects of nicotinic acid on human purine metabolism.
Topics: Adult; Aspirin; Creatinine; Erythrocytes; Female; Gout; Humans; Iopanoic Acid; Kidney Tubules; Male; Middle Aged; Niacinamide; Nicotinic Acids; Organophosphorus Compounds; Pentosephosphates; Pentosyltransferases; Phosphoric Acids; Purines; Pyrazinamide; Pyridines; Sulfinpyrazone; Uric Acid | 1974 |
Bradykinin induced bronchoconstriction in guinea pigs and its modification by various agents.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Antipyrine; Aspirin; Bradykinin; Bronchi; Chlorpromazine; Drug Antagonism; Drug Synergism; Ethanolamines; Female; Guinea Pigs; Histamine; Indomethacin; Male; Methysergide; Oxyphenbutazone; Phenacetin; Phenoxybenzamine; Phenylbutazone; Sulfinpyrazone; Tripelennamine | 1967 |
[Incidence of thrombosis and the status of coagulation in ischaemic heart disease].
Topics: Acute Disease; Aspirin; Blood Coagulation; Chronic Disease; Coronary Disease; Depression, Chemical; Humans; Indomethacin; Myocardial Infarction; Phenylbutazone; Platelet Adhesiveness; Platelet Aggregation; Sulfinpyrazone | 1974 |
Effect of antilymphocyte globulin on platelets.
Topics: Antilymphocyte Serum; Aspirin; Blood Platelets; Cross Reactions; Dipyridamole; Flurbiprofen; Humans; Platelet Aggregation; Prostaglandins E; Serotonin; Sulfinpyrazone | 1974 |
Platelets.
Topics: Aspirin; Blood Platelets; Dipyridamole; Humans; Sulfinpyrazone; Thromboembolism | 1973 |
Evidence for a postsecretory reabsorptive site for uric acid in man.
Topics: Absorption; Adult; Aspirin; Female; Humans; Kidney Tubules; Male; Middle Aged; Probenecid; Pyrazinamide; Sulfinpyrazone; Uric Acid | 1973 |
Heterophile antibodies and tissue injury. 3. A role for platelets in the development of lethal vascular injury during Forssman shock in guinea pigs.
Topics: Anaphylaxis; Animals; Antibodies, Heterophile; Aspirin; Blood Cell Count; Blood Platelet Disorders; Blood Platelets; Blood Vessels; Capillaries; Carbon Isotopes; Complement System Proteins; Forssman Antigen; Guinea Pigs; Immune Sera; Leukocytes; Liver; Lung; Microscopy, Electron; Mortality; Rabbits; Serotonin; Sheep; Spleen; Sulfinpyrazone; Time Factors | 1973 |
The treatment of gout.
Topics: Acute Disease; Allopurinol; Aspirin; Colchicine; Drug Therapy, Combination; Gout; Indomethacin; Phenylbutazone; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1973 |
Address of the president-elect: the indication for various methods of treatment of occlusive cerebrovascular disease.
Topics: Anticoagulants; Aspirin; Blood Pressure; Cardiac Output; Carotid Arteries; Cerebral Angiography; Cerebrovascular Circulation; Cerebrovascular Disorders; Dipyridamole; Electroencephalography; Giant Cell Arteritis; Humans; Intracranial Arteriosclerosis; Intracranial Embolism and Thrombosis; Ischemic Attack, Transient; Methods; Neurologic Examination; Polycythemia; Radionuclide Imaging; Sulfinpyrazone | 1973 |
The binding of urate to plasma proteins.
Topics: Allopurinol; Aspirin; Binding Sites; Blood Proteins; Colchicine; Dialysis; Evaluation Studies as Topic; Gout; Humans; Hydrogen-Ion Concentration; Indomethacin; Kidney Diseases; Kinetics; Methods; Osmolar Concentration; Phenylbutazone; Probenecid; Protein Binding; Serum Albumin; Solubility; Sulfinpyrazone; Temperature; Time Factors; Uric Acid | 1974 |
Evidence for a post-secretory reabsorptive site for uric acid in man.
Topics: Aspirin; Biological Transport; Fasting; Humans; Kidney Tubules; Probenecid; Pyrazinamide; Sulfinpyrazone; Time Factors; Uric Acid | 1974 |
Apparent similarity of mechanisms of platelet adhesion and aggregation. Differentiation of these functions from clot retraction.
Topics: Amitriptyline; Aspirin; Blood Coagulation Tests; Caffeine; Chloromercuribenzoates; Chlorpromazine; Clot Retraction; Cocaine; Diphenhydramine; Ethacrynic Acid; Guanidines; Humans; Phenothiazines; Phentolamine; Phenylbutazone; Platelet Adhesiveness; Promethazine; Quinacrine; Quinidine; Reserpine; Sulfinpyrazone; Sulfones; Tosyl Compounds | 1972 |
Effect of drugs on the binding of urate to human albumin.
Topics: Allopurinol; Aspirin; Colchicine; Humans; Indomethacin; Phenylbutazone; Probenecid; Protein Binding; Serum Albumin; Sulfinpyrazone; Uric Acid | 1970 |
Effect of acetylsalicylic acid, other nonsteroidal anti-inflammatory agents, and dipyridamole on human blood platelets.
Topics: Adenine Nucleotides; Anti-Inflammatory Agents; Aspirin; Blood Platelets; Carbon Isotopes; Centrifugation; Connective Tissue; Dipyridamole; Drug Synergism; Epinephrine; Flufenamic Acid; Humans; Indomethacin; Mefenamic Acid; Phenylbutazone; Serotonin; Sodium Salicylate; Sulfinpyrazone | 1970 |
Effect of some uricosuric and anti-inflammatory drugs on the binding of uric acid to human serum albumin in vitro.
Topics: Allopurinol; Anti-Inflammatory Agents; Aspirin; Binding Sites; Caprylates; Colchicine; Dialysis; Fluorescence; Humans; In Vitro Techniques; Indomethacin; Mefenamic Acid; Phenylbutazone; Probenecid; Protein Binding; Serum Albumin; Sodium Salicylate; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1970 |
Pharmacological studies of a new anti-inflammatory drug, 1-phenylsulfonyl-5,5-diphenylhydantoin (PC-796) in experimental animals. II. Toxicological and general pharmacological properties.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Autonomic Nervous System; Blood Circulation; Blood Glucose; Body Weight; Central Nervous System; Cholesterol; Endocrine Glands; Food; Hematocrit; Hemoglobins; Hydantoins; Phenylbutazone; Rats; Stomach Ulcer; Sulfinpyrazone; Sulfones; Uricosuric Agents; Water-Electrolyte Balance; Wound Healing | 1970 |
The effect of mefenamic acid and flufenamic acid on plasma uric acid levels.
Topics: Anti-Inflammatory Agents; Aspirin; Flufenamic Acid; Humans; Mefenamic Acid; ortho-Aminobenzoates; Sulfinpyrazone; Uric Acid | 1966 |
Induction of periarthritis by oral administration of 6-sulfanilamidoindazole and its treatment in rats.
Topics: Animals; Aspirin; Chloroquine; Cloxacillin; Hydralazine; Hydrocortisone; Indomethacin; Male; Mercaptopurine; Methotrexate; Morphine; ortho-Aminobenzoates; Oxyphenbutazone; Paramethasone; Periarthritis; Phenylbutazone; Rats; Sulfinpyrazone; Sulfonamides | 1967 |
Treatment of the patient after myocardial infarction. The last decade and the next.
Topics: Adrenergic beta-Antagonists; Aspirin; Death, Sudden; Exercise Therapy; Humans; Myocardial Infarction; Myocardial Revascularization; Prognosis; Sulfinpyrazone | 1980 |
Sulphinpyrazone, aspirin, and uric acid.
Topics: Aspirin; Blood Platelets; Humans; Sulfinpyrazone; Uric Acid | 1980 |
Placebo-controlled, double-blind clinical trials can impede medical progress.
Topics: Adrenergic beta-Antagonists; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Double-Blind Method; Drug Therapy; Evaluation Studies as Topic; Humans; Ischemic Attack, Transient; Myocardial Infarction; Placebos; Sulfinpyrazone | 1980 |
Antiplatelet drugs in the secondary prevention of myocardial infarction. One view of the present position.
Topics: Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Humans; Myocardial Infarction; Recurrence; Risk; Sulfinpyrazone; Thrombosis | 1980 |
[Role of medical treatment in the rehabilitation of the coronary patient].
Topics: Adrenergic beta-Antagonists; Anticoagulants; Aspirin; Coronary Disease; Heart Diseases; Humans; Myocardial Infarction; Sulfinpyrazone | 1981 |
[Prevention of recurrent myocardial infarct].
Topics: Adrenergic beta-Antagonists; Aspirin; Humans; Myocardial Infarction; Recurrence; Sulfinpyrazone | 1981 |
[Inhibitors of thrombocytic function for prophylaxis of coronary heart disease (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anticoagulants; Arteriosclerosis; Aspirin; Coronary Disease; Dipyridamole; Female; Humans; Male; Middle Aged; Platelet Aggregation; Prospective Studies; Sulfinpyrazone | 1982 |
[Infarction prophylaxis--prevention of the sudden heart death? An alternative].
Topics: Adrenergic beta-Antagonists; Anticoagulants; Aspirin; Dipyridamole; Female; Heart Arrest; Humans; Male; Myocardial Infarction; Sulfinpyrazone | 1982 |
Overview of recent clinical and methodological advances from clinical trials of cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Aspirin; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Disease; Humans; Hypertension; Myocardial Infarction; Random Allocation; Recurrence; Research Design; Sulfinpyrazone | 1982 |
Therapeutic interventions in acute myocardial infarction. Survey of the ACCP Section on Clinical Cardiology.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Calcium Channel Blockers; Digitalis Glycosides; Dipyridamole; Drug Utilization; Hospitalization; Humans; Myocardial Infarction; Nitrates; Societies, Medical; Sulfinpyrazone; United States | 1984 |
[Current status of medical treatment].
Topics: Aminophylline; Animals; Anticoagulants; Aspirin; Barbiturates; Brain Ischemia; Cerebrovascular Disorders; Dextrans; Epoprostenol; Glucose; Glycerol; Heparin; Humans; Indomethacin; Pentoxifylline; Sulfinpyrazone | 1980 |
[Benefits and dangers of preventive thinking in medicine--prevention of thromboembolism].
Topics: Adult; Aspirin; Bandages; Blood Flow Velocity; Coumarins; Dextrans; Dihydroergotamine; Dipyridamole; Hemodilution; Humans; Middle Aged; Myocardial Infarction; Streptokinase; Sulfinpyrazone; Thromboembolism | 1981 |
Treatment of cerebral ischemia.
Topics: Aspirin; Brain Ischemia; Carotid Arteries; Dicumarol; Dipyridamole; Endarterectomy; Heart Murmurs; Heparin; Humans; Hypertension; Ischemic Attack, Transient; Risk; Sulfinpyrazone; Warfarin | 1981 |
Pharmacology of angioplasty and intravascular thrombolysis.
Topics: Angioplasty, Balloon; Anticoagulants; Arteriosclerosis; Aspirin; Blood Platelets; Dextrans; Dipyridamole; Heparin; Humans; Middle Aged; Prostaglandins; Streptokinase; Sulfinpyrazone; Thromboembolism; Urokinase-Type Plasminogen Activator; Warfarin | 1982 |
Antithrombotic treatment.
Topics: Ancrod; Aspirin; Cerebrovascular Disorders; Dextrans; Dipyridamole; Drug Administration Schedule; Heparin; Humans; Myocardial Infarction; Recurrence; Sulfinpyrazone; Thrombosis | 1983 |
Antiplatelet drugs.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Dextrans; Dipyridamole; Epoprostenol; Humans; Sulfinpyrazone; Vascular Diseases | 1983 |
[Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders].
Topics: Adrenergic beta-Antagonists; Aged; Anticoagulants; Aspirin; Coumarins; Dicumarol; Dipyridamole; Fibrinolytic Agents; Heparin; Humans; Myocardial Infarction; Platelet Aggregation; Streptokinase; Sulfinpyrazone | 1984 |
Effect of antiplatelet therapy on restenosis after experimental angioplasty.
Topics: Angioplasty, Balloon; Animals; Arteriosclerosis; Aspirin; Blood Platelets; Dipyridamole; Iliac Artery; Rabbits; Radiography; Recurrence; Sulfinpyrazone | 1984 |
The thrombogenicity of Dacron arterial grafts and its modification by platelet inhibitory drugs.
Topics: Arteries; Aspirin; Blood Platelets; Blood Vessel Prosthesis; Dipyridamole; Drug Therapy, Combination; Humans; Microscopy, Electron; Platelet Adhesiveness; Platelet Aggregation; Polyethylene Terephthalates; Sulfinpyrazone; Thiophenes; Thrombosis; Ticlopidine | 1984 |
[Prevention of thrombosis by thrombocyte inhibitors. 1. Cell regulation mechanisms and pharmacological modification].
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Cyclic AMP; Dextrans; Dipyridamole; Humans; Hydroxychloroquine; Indomethacin; Platelet Aggregation; Prostaglandins; Sulfinpyrazone; Thrombosis; Thromboxane A2 | 1980 |
Effects of sulfinpyrazone, aspirin and propranolol on the isoproterenol-induced myocardial necrosis.
Topics: Animals; Aspirin; Body Weight; Creatine Kinase; Cyclic AMP; Heart; Isoproterenol; Male; Myocardial Infarction; Myocardium; Necrosis; Organ Size; Propranolol; Prostaglandins; Rats; Rats, Inbred Strains; Sulfinpyrazone | 1981 |
[Cerebrovascular complications of thrombocytosis].
Topics: Aged; Aspirin; Blindness; Cerebellar Diseases; Cerebellopontine Angle; Facial Paralysis; Female; Humans; Middle Aged; Nystagmus, Pathologic; Paresis; Paresthesia; Sulfinpyrazone; Thrombocytosis; Vertigo | 1983 |
[Divergence between the pharmacologic and clinical effects of inhibitors of prostaglandin synthesis].
Topics: Aspirin; Blood Platelets; Dipyridamole; Drug Interactions; Epoprostenol; Humans; Platelet Aggregation; Prostaglandin Antagonists; Prostaglandin-Endoperoxide Synthases; Salicylates; Salicylic Acid; Sulfinpyrazone; Thrombosis; Thromboxanes | 1984 |
Prostaglandin endoperoxides and thromboxane A2 in thrombus formation in the hamster cheek pouch in vivo.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Cheek; Cricetinae; Cyclooxygenase Inhibitors; Dipyridamole; Epoprostenol; Male; Mesocricetus; Microscopy, Electron; Platelet Aggregation; Sulfinpyrazone; Thrombosis; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1984 |
Antithrombotic therapy for vascular prosthesis: an experimental model testing platelet inhibitory drugs.
Topics: Aspirin; Blood Circulation; Blood Platelets; Blood Vessel Prosthesis; Dipyridamole; Humans; Methods; Microscopy, Electron, Scanning; Platelet Adhesiveness; Platelet Aggregation; Polyethylene Terephthalates; Sulfinpyrazone; Thrombosis | 1980 |
Inhibition of thrombocytopenic episodes caused by the Arthus reaction, the sub-lethal Forssman reaction and ADP.
Topics: Adenosine Diphosphate; Animals; Antibodies; Arthus Reaction; Aspirin; Dipyridamole; Forssman Antigen; Guinea Pigs; Humans; Nervous System Diseases; Platelet Count; Pyridines; Sulfides; Sulfinpyrazone; Thiophenes; Thrombocytopenia; Ticlopidine | 1980 |
The effect of aspirin on the pharmacokinetics of sulfinpyrazone in man.
Topics: Adult; Aspirin; Drug Interactions; Half-Life; Humans; Kinetics; Male; Sulfinpyrazone | 1983 |
The relationship between basic biomedical research and the design and analysis of clinical trials.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Humans; Kinetics; Research Design; Sulfinpyrazone | 1983 |
Ex vivo and in vivo evaluation of drugs that inhibit platelet function.
Topics: Adenosine Diphosphate; Animals; Aspirin; Bleeding Time; Blood Platelets; Collagen; Dipyridamole; Imidazoles; Male; Papio; Platelet Aggregation; Sulfinpyrazone; Thiazines; Thiophenes; Ticlopidine | 1983 |
Drugs in the treatment of thrombo-embolic disease--part I.
Topics: Administration, Oral; Anticoagulants; Aspirin; Blood Platelets; Carotid Artery Diseases; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Dose-Response Relationship, Drug; Gastrointestinal Hemorrhage; Heart Valve Prosthesis; Humans; Hydroxychloroquine; Sulfinpyrazone; Thromboembolism; Thrombophlebitis | 1983 |
Use of common antiplatelet drugs for vascular diseases.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Artery Bypass; Coronary Disease; Coumarins; Dipyridamole; Fibrinolytic Agents; Heart Valve Prosthesis; Heart Valves; Humans; Postoperative Care; Sulfinpyrazone | 1983 |
Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response of pulmonary tissues.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Aspirin; Blood Platelets; Catechols; Chromones; Dose-Response Relationship, Drug; Guinea Pigs; Indomethacin; Lung; Masoprocol; Muscle Contraction; Muscle, Smooth; Platelet Activating Factor; Rats; Sulfinpyrazone; Thromboxane B2 | 1983 |
Diagnosis and management of ischemic stroke. Part I.--Threatened stroke and its management.
Topics: Anticoagulants; Arrhythmias, Cardiac; Aspirin; Brain Ischemia; Carotid Artery Thrombosis; Cerebral Angiography; Cerebral Infarction; Endarterectomy; Heart Diseases; Humans; Intracranial Embolism and Thrombosis; Ischemic Attack, Transient; Sulfinpyrazone; Tomography, X-Ray Computed | 1983 |
[Present status of the therapy of acute cerebral transient ischemic attacks].
Topics: Acute Disease; Aspirin; Carotid Arteries; Cerebral Infarction; Drug Therapy, Combination; Endarterectomy; Female; Follow-Up Studies; Humans; Ischemic Attack, Transient; Male; Sulfinpyrazone | 1983 |
[Platelet antiaggregants in post-myocardial infarct patients: why, which and in what doses?].
Topics: Aspirin; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation; Recurrence; Sulfinpyrazone | 1983 |
The effects of antithrombotic drugs in patients with left ventricular thrombi: assessment with indium-111 platelet imaging and two-dimensional echocardiography.
Topics: Adult; Aged; Anticoagulants; Aspirin; Dipyridamole; Echocardiography; Heart Ventricles; Humans; Indium; Male; Middle Aged; Platelet Aggregation; Prospective Studies; Radioisotopes; Radionuclide Imaging; Sulfinpyrazone; Thrombosis; Warfarin | 1984 |
[Is modern anti-aggregation therapy effective?].
Topics: Aspirin; Dipyridamole; Fibrinolytic Agents; Humans; Platelet Aggregation; Sulfinpyrazone; Thromboembolism | 1984 |
Anticoagulants and platelet-active agents in the secondary prevention of coronary artery disease.
Topics: Aged; Anticoagulants; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Epoprostenol; Humans; Middle Aged; Myocardial Infarction; Netherlands; Recurrence; Sulfinpyrazone | 1982 |
[Sulfinpyrazone (Anturane)--new indication: myocardial infarct?].
Topics: Arrhythmias, Cardiac; Aspirin; Death, Sudden; Humans; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone | 1980 |
Platelet adhesion to collagen in normal and von Willebrand's disease subjects.
Topics: Animals; Aspirin; Blood Platelets; Collagen; Diabetes Mellitus; Dipyridamole; Factor VIII; Humans; Kidney Diseases; Platelet Adhesiveness; Platelet Count; Rats; Sulfinpyrazone; Temperature; von Willebrand Diseases | 1980 |
[Influence of platelet aggregation inhibitors on platelet damage at prosthetic heart valves in-vitro (author's transl)].
Topics: Aspirin; Blood Platelets; Dipyridamole; Heart Valve Prosthesis; Hemolysis; Humans; Lysine; Platelet Aggregation; Propionates; Sulfinpyrazone | 1981 |
Sulphinpyrazone prevents in vivo the inhibitory effect of aspirin on rat platelet cyclo-oxygenase activity.
Topics: Animals; Arachidonic Acids; Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; Drug Interactions; Kinetics; Male; Malondialdehyde; Rats; Sulfinpyrazone | 1981 |
The effect of sulphinpyrazone on whole blood thromboxane and prostacyclin generation in man.
Topics: Adult; Aspirin; Collagen; Cyclooxygenase Inhibitors; Depression, Chemical; Epoprostenol; Humans; Leukocytes; Platelet Aggregation; Prostaglandins; Radioimmunoassay; Stimulation, Chemical; Sulfinpyrazone; Thromboxane A2; Thromboxanes; Time Factors | 1982 |
Veno-venous allografts: patency, subendothelial proliferation, and the role of platelet-active agents.
Topics: Animals; Aspirin; Blood Platelets; Cell Division; Dipyridamole; Dogs; Female; Graft Survival; Male; Muscle, Smooth, Vascular; Phthalazines; Sulfinpyrazone; Thrombosis; Transplantation, Autologous; Transplantation, Homologous; Veins | 1983 |
Antithrombotic therapy.
Topics: Anticoagulants; Aspirin; Blood Platelets; Dipyridamole; Fibrinolytic Agents; Humans; Sulfinpyrazone; Thrombosis | 1983 |
Dermatomyositis associated with platelet thrombi formation and responsive to antiplatelet therapy.
Topics: Adult; Aspirin; Blood Platelets; Dermatomyositis; Dipyridamole; Female; Humans; Sulfinpyrazone; Thrombosis | 1983 |
Protection from arrhythmias of cultured heart cells by nonsteroidal antiinflammatory drugs.
Topics: Animals; Animals, Newborn; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Aspirin; Cells, Cultured; Indomethacin; Rats; Salicylates; Salicylic Acid; Sulfinpyrazone; Time Factors | 1983 |
The prevention of prosthetic valve thromboembolism. Uses and limitations of anti-platelet drugs.
Topics: Anticoagulants; Aspirin; Bioprosthesis; Dipyridamole; Drug Therapy, Combination; Heart Valve Prosthesis; Humans; Sulfinpyrazone; Thromboembolism | 1983 |
[Conservative therapy of stroke from an internist's viewpoint].
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Digitalis Glycosides; Dipyridamole; Diuretics; Heart Failure; Heme; Humans; Mitral Valve Prolapse; Platelet Aggregation; Sulfinpyrazone; Vasodilator Agents | 1983 |
Comparative effects of acetylsalicylic acid (ASA) and sulfinpyrazone on isoproterenol-induced heart damage.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Urea Nitrogen; Creatine Kinase; Isoproterenol; Male; Myocardial Infarction; Prostaglandins F; Rats; Sulfinpyrazone; Thromboxane B2 | 1981 |
Myocardial infarction and aspirin.
Topics: Aspirin; Humans; Myocardial Infarction; Recurrence; Sulfinpyrazone | 1980 |
Non-steroidal anti-inflammatory agents and coronary heart disease.
Topics: Animals; Anti-Inflammatory Agents; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Carotid Artery Diseases; Coronary Disease; Dipyridamole; Female; Fibrin; Humans; Male; Prostaglandins; Sex Factors; Sulfinpyrazone; Thrombosis | 1980 |
[Present situation of therapy with platelet aggregation inhibitors].
Topics: Adult; Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Humans; Middle Aged; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone; Thromboembolism; Vascular Diseases | 1982 |
Antiplatelet therapy.
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Epoprostenol; Female; Heart Valve Prosthesis; Humans; Male; Platelet Aggregation; Sulfinpyrazone; Thrombophlebitis | 1981 |
Platelets and coronary heart disease: therapy update.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Epoprostenol; Hemostasis; Humans; Propranolol; Prostaglandin Antagonists; Risk; Sulfinpyrazone; Thromboxane A2 | 1982 |
Transient cerebral ischaemic attacks.
Topics: Anticoagulants; Aspirin; Carotid Arteries; Carotid Artery Diseases; Diagnosis, Differential; Humans; Ischemic Attack, Transient; Radiography; Sulfinpyrazone | 1982 |
[Prevention of cardiovascular diseases by inhibitors of platelet aggregation (author's transl)].
Topics: Anti-Inflammatory Agents; Aspirin; Cardiovascular Diseases; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1982 |
[Preventive drug therapy of transient cerebral ischemic attacks].
Topics: Anticoagulants; Aspirin; Dipyridamole; Humans; Ischemic Attack, Transient; Platelet Aggregation; Sulfinpyrazone | 1982 |
[A contribution to the study of blood platelet aggregation].
Topics: Aspirin; Coronary Disease; Humans; Platelet Aggregation; Sulfinpyrazone | 1982 |
Sex difference in circulating platelet aggregates and response to antiplatelet treatment.
Topics: Aspirin; Female; Humans; Male; Platelet Aggregation; Sex Factors; Sulfinpyrazone; Thromboembolism | 1982 |
Inhibitors of immune complex induced human platelet aggregation and release in plasma.
Topics: Antibodies; Antigen-Antibody Complex; Aspirin; Blood Platelets; Depression, Chemical; Dipyridamole; DNA; Humans; Imidazoles; Indomethacin; Lupus Erythematosus, Systemic; Male; Platelet Aggregation; Quinazolines; Receptors, Fc; Sulfinpyrazone | 1982 |
Thrombotic thrombocytopenic purpura.
Topics: Adult; Aspirin; Blood Transfusion; Dipyridamole; Female; Humans; Prednisone; Purpura, Thrombotic Thrombocytopenic; Sulfinpyrazone | 1980 |
[Thrombotic thrombocytopenic purpura: report on 5 cases and current therapy concepts].
Topics: Adult; Aspirin; Dipyridamole; Evaluation Studies as Topic; Exchange Transfusion, Whole Blood; Female; Humans; Male; Prednisone; Pregnancy; Pregnancy Complications, Hematologic; Prognosis; Purpura, Thrombotic Thrombocytopenic; Splenectomy; Sulfinpyrazone | 1981 |
Thrombotic thrombocytopenic purpura: prolonged coma with recovery of neurologic function with intensive plasma exchange.
Topics: Aspirin; Coma; Dipyridamole; Female; Humans; Middle Aged; Plasma Exchange; Platelet Count; Prednisolone; Purpura, Thrombotic Thrombocytopenic; Sulfinpyrazone; Vincristine | 1981 |
Modulation of the inhibitory action of prostaglandin E1 on platelet aggregation in rats: a study with ticlopidine, aspirin, dipyridamole and sulfinpyrazone.
Topics: Adenosine Diphosphate; Alprostadil; Animals; Aspirin; Dipyridamole; Male; Phosphorylation; Platelet Aggregation; Prostaglandins E; Rats; Rats, Inbred Strains; Sulfinpyrazone; Thiophenes; Ticlopidine | 1982 |
Effect of non-steroid anti-inflammatory drugs in experimental myocardial infarction in rats.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Coronary Vessels; Indomethacin; Male; Myocardial Infarction; Rats; Salicylates; Sulfinpyrazone | 1981 |
Sulfinpyrazone and aspirin increase epicardial coronary collateral flow in dogs.
Topics: Animals; Aspirin; Blood Pressure; Collateral Circulation; Constriction, Pathologic; Coronary Vessels; Dogs; Female; Heart Rate; Hemodynamics; Male; Platelet Aggregation; Sulfinpyrazone | 1981 |
Indium-111 platelet imaging for detection of platelet deposition in abdominal aneurysms and prosthetic arterial grafts.
Topics: Abdomen; Aged; Aneurysm; Aortic Aneurysm; Arteries; Aspirin; Bioprosthesis; Blood Coagulation; Blood Platelets; Dipyridamole; Humans; Indium; Male; Middle Aged; Radioisotopes; Radionuclide Imaging; Sulfinpyrazone | 1981 |
Therapy of ischemic cerebrovascular disease.
Topics: Anticoagulants; Aspirin; Brain Ischemia; Carotid Arteries; Cerebrovascular Disorders; Endarterectomy; Follow-Up Studies; Humans; Middle Aged; Sulfinpyrazone | 1980 |
Effects of very low versus standard dose acetyl salicylic acid, dipyridamole and sulfinpyrazone on platelet function and thromboxane formation in man.
Topics: Adenosine Diphosphate; Adult; Arachidonic Acids; Aspirin; Blood Platelets; Collagen; Dipyridamole; Dose-Response Relationship, Drug; Female; Humans; Male; Platelet Aggregation; Sulfinpyrazone; Thromboxane B2; Thromboxanes | 1981 |
[Treatment and prevention of thromboembolism with anti-aggregation drugs].
Topics: Aspirin; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone; Thromboembolism | 1981 |
Preservation of platelets during extracorporeal circulation in sheep. A comparison between aspirin and sulfinpyrazone.
Topics: Animals; Aspirin; Blood Platelets; Blood Preservation; Blood Pressure; Extracorporeal Circulation; Leukocyte Count; Oxygenators; Platelet Count; Pulmonary Artery; Sheep; Sulfinpyrazone; Thromboxane B2 | 1981 |
Mechanisms of Forssman-induced bronchospasm and their inhibition.
Topics: Animals; Aspirin; Blood Platelets; Bronchial Spasm; Complement System Proteins; Forssman Antigen; Guinea Pigs; Immune Sera; Indomethacin; Neuraminidase; Pressure; Salicylates; Sulfinpyrazone | 1981 |
[Sulfinpyrazone and aspirin in experimental microthrombosis].
Topics: Animals; Aspirin; Blood Vessels; Endothelium; Platelet Aggregation; Rats; Rats, Inbred Strains; Sulfinpyrazone; Thrombosis; Time Factors | 1981 |
Antiplatelet drugs after myocardial infarction.
Topics: Aspirin; Dipyridamole; Humans; Ischemic Attack, Transient; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone | 1980 |
Relationship of plasma anti-heparin activity and platelet survival time in coronary disease.
Topics: Aspirin; Blood Coagulation Factors; Blood Platelets; Cell Survival; Coronary Disease; Dipyridamole; Double-Blind Method; Humans; Indomethacin; Male; Platelet Factor 4; Sulfinpyrazone; Time Factors | 1980 |
[Multicenter studies in the USA and Canada: thrombocyte function inhibitor in ischemic cerebrovascular diseases].
Topics: Aspirin; Blood Platelets; Brain Ischemia; Canada; Female; Humans; Male; Sulfinpyrazone; United States | 1980 |
Prevention of thrombosis with antiplatelet drugs.
Topics: Aspirin; Blood Platelets; Dipyridamole; Humans; Sulfinpyrazone; Thrombosis | 1980 |
Preventing death after myocardial infarction.
Topics: Aspirin; Humans; Myocardial Infarction; Platelet Aggregation; Recurrence; Sulfinpyrazone | 1980 |
Studies of myocardial infarction.
Topics: Aspirin; Dipyridamole; Drug Combinations; Gastrointestinal Diseases; Humans; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone | 1980 |
Sulfinpyrazone and aspirin-induced asthma.
Topics: Anaphylaxis; Aspirin; Asthma; Bronchial Spasm; Dipyrone; Drug Hypersensitivity; Humans; Sulfinpyrazone | 1980 |
Thromboxane B2 and 6-keto-prostaglandin F1 alpha synthesis during infusion of collagen and arachidonic acid in rabbits: inhibition by aspirin and sulfinpyrazone.
Topics: Animals; Arachidonic Acids; Aspirin; Blood Pressure; Collagen; Dose-Response Relationship, Drug; Female; Platelet Aggregation; Platelet Count; Prostaglandins F; Rabbits; Sulfinpyrazone; Thromboxane B2; Thromboxanes | 1980 |
Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist.
Topics: Agranulocytosis; Arachidonic Acids; Aspirin; Cell Adhesion; Chemotactic Factors; Chemotaxis, Leukocyte; Dose-Response Relationship, Drug; Humans; Indomethacin; Methionine; N-Formylmethionine; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oligopeptides; Phenylbutazone; Sulfinpyrazone | 1980 |
[Sulfinpyrazone (Anturan) after myocardial infarction].
Topics: Aspirin; Female; Humans; Male; Middle Aged; Myocardial Infarction; Recurrence; Sulfinpyrazone | 1980 |
[Indications for surgical treatment and medical treatment of atherosclerosis].
Topics: Arteriosclerosis; Aspirin; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Dipyridamole; Humans; Hyperlipidemias; Hypolipidemic Agents; Intracranial Arteriosclerosis; Nicotinic Acids; Sitosterols; Sulfinpyrazone | 1980 |
[Anti-platelet-aggregating drugs. Clinical pharmacology and therapeutic use].
Topics: Aspirin; Blood Platelet Disorders; Brain Ischemia; Clofibrate; Coronary Disease; Dipyridamole; Humans; Myocardial Infarction; Platelet Aggregation; Sulfinpyrazone; Thromboembolism; Thrombophlebitis | 1980 |
Therapeutic implications of drug interactions with acetaminophen and aspirin.
Topics: Acetaminophen; Antacids; Anticoagulants; Aspirin; Drug Interactions; Humans; Methotrexate; Propantheline; Sulfinpyrazone | 1981 |
[Drug interactions in therapy of cardiac decompensation].
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Digoxin; Diuretics; Drug Interactions; Heart Failure; Histamine H2 Antagonists; Humans; Sulfinpyrazone | 1994 |
Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts.
Topics: Anticoagulants; Aspirin; Coronary Artery Bypass; Dipyridamole; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Internal Mammary-Coronary Artery Anastomosis; Saphenous Vein; Sulfinpyrazone; Ticlopidine | 1998 |
[ATTEMPTED INHIBITION OF BRADYKININ-INDUCED EDEMA IN RATS].
Topics: Adrenocorticotropic Hormone; Aldosterone; Analgesics; Analgesics, Non-Narcotic; Antipyretics; Ascorbic Acid; Aspirin; Bradykinin; Corticosterone; Cortisone; Desoxycorticosterone; Edema; Oxyphenbutazone; Pharmacology; Phenylbutazone; Rats; Research; Sodium Salicylate; Sulfinpyrazone; Toxicology; Uricosuric Agents | 1963 |
[CASE OF CHRONIC TOPHOCEOUS GOUT].
Topics: Arthritis, Gouty; Aspirin; Diet; Diet Therapy; Gout; Humans; Phenylbutazone; Prednisolone; Sulfinpyrazone; Uric Acid; Uricosuric Agents | 1963 |
[THE TREATMENT OF CHRONIC INFLAMMATORY RHEUMATISM IN ADULTS].
Topics: Adrenal Cortex Hormones; Antimalarials; Arthritis; Arthritis, Rheumatoid; Aspirin; Colchicine; Collagen Diseases; Cortisone; Exercise Therapy; Gold; Gout; Humans; Mineral Waters; Phenylbutazone; Probenecid; Rheumatic Fever; Spondylitis; Spondylitis, Ankylosing; Sulfinpyrazone; Uricosuric Agents; Zoxazolamine | 1964 |
INHIBITORS OF PENICILLIN BINDING TO SERUM PROTEINS.
Topics: Acetazolamide; Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antimetabolites; Aspirin; Benzoates; Biguanides; Blood Proteins; Carbon Isotopes; Chlorothiazide; Diuretics; Ethacrynic Acid; Guanidines; Oxazoles; p-Aminohippuric Acid; Penicillin G; Penicillin V; Penicillins; Pharmacology; Phenylbutazone; Probenecid; Rabbits; Research; Salicylates; Sulfinpyrazone; Sulfonamides; Tolbutamide | 1965 |